{"metadata":{"kernelspec":{"language":"python","display_name":"Python 3","name":"python3"},"language_info":{"name":"python","version":"3.12.12","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"},"kaggle":{"accelerator":"none","dataSources":[{"sourceId":14181149,"sourceType":"datasetVersion","datasetId":9040517},{"sourceId":14241273,"sourceType":"datasetVersion","datasetId":9085789}],"dockerImageVersionId":31236,"isInternetEnabled":true,"language":"python","sourceType":"notebook","isGpuEnabled":false}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"code","source":"with open('/kaggle/input/vlsp-nlp/train.en.txt', 'r', encoding='utf-8') as f:\n    ens = f.read().splitlines()\n\nwith open('/kaggle/input/vlsp-nlp/train.vi.txt', 'r', encoding='utf-8') as f:\n    vis = f.read().splitlines()\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:07:42.166508Z","iopub.execute_input":"2025-12-21T13:07:42.166868Z","iopub.status.idle":"2025-12-21T13:07:43.495904Z","shell.execute_reply.started":"2025-12-21T13:07:42.166840Z","shell.execute_reply":"2025-12-21T13:07:43.494671Z"}},"outputs":[],"execution_count":201},{"cell_type":"code","source":"import random\n\nfor i, (en, vi) in enumerate(random.sample(list(zip(ens, vis)), 5), 1):\n    print(f\"Sample {i}\")\n    print(\"EN:\", en)\n    print(\"VI:\", vi)\n    print(\"-\" * 40)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:07:43.497898Z","iopub.execute_input":"2025-12-21T13:07:43.498207Z","iopub.status.idle":"2025-12-21T13:07:43.767025Z","shell.execute_reply.started":"2025-12-21T13:07:43.498174Z","shell.execute_reply":"2025-12-21T13:07:43.766075Z"}},"outputs":[{"name":"stdout","text":"Sample 1\nEN: Percentage of students with eyeglasses for refractive adjustment was 35.0% inwhich girls with glasses accounted for 40.9%, and boys with glasses were 28.6%. The percentage of pupils with glasses increased with age, the percentage of students with glasses at urban areas was 45.6%, which was higher than the suburbs (13.5%).\nVI: Tỷ lệ học sinh mang kính điều chỉnh tật khúc xạ là 35,0% trong đó học sinh nữ (40,9%) nhiều hơn so với học sinh nam (28,6%); tỷ lệ học sinh mang kính tăng theo độ tuổi, tỷ lệ học sinh mang kính thuộc khu vực nội thành (45,6%) cao hơn so với ngoại thành (13,5%).\n----------------------------------------\nSample 2\nEN: Air insufflation (pneumatic otoscopy) shows poor mobility of the TM.\nVI: Giảm thông khí tai giữa (ống soi tai có bơm hơi) cho thấy tính di động kém của màng nhĩ.\n----------------------------------------\nSample 3\nEN: These infections are more common among patients with immunocompromise due to another disorder (eg, alcohol use disorder).\nVI: Nhiễm trùng này phổ biến hơn ở những bệnh nhân suy giảm miễn dịch do rối loạn khác (ví dụ như nghiện rượu).\n----------------------------------------\nSample 4\nEN: Smiles that do not reveal to the upper first molars are the most common (90.92%), with no difference between men and women.\nVI: Nụ cười không bộc lộ đến răng hàm lớn thứ nhất hàm trên là phổ biến (90,92%), không có khác biệt giữa nam và nữ.\n----------------------------------------\nSample 5\nEN: Report a case of intussuscepted sigmoid colon into the rectum protruding from the anus, without rectal prolapse, and eventually large bowel obstruction.\nVI: Mô tả một trường hợp ít gặp ung thư biểu mô của đại tràng chậu hông gây lồng đại tràng chậu hông trực tràng, không sa trực tràng và dần dần gây tắc ruột.\n----------------------------------------\n","output_type":"stream"}],"execution_count":202},{"cell_type":"code","source":"print(len(ens))\nprint(len(set(ens)))","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:07:43.768017Z","iopub.execute_input":"2025-12-21T13:07:43.768367Z","iopub.status.idle":"2025-12-21T13:07:43.988323Z","shell.execute_reply.started":"2025-12-21T13:07:43.768342Z","shell.execute_reply":"2025-12-21T13:07:43.986616Z"}},"outputs":[{"name":"stdout","text":"500000\n346403\n","output_type":"stream"}],"execution_count":203},{"cell_type":"code","source":"print(len(vis))\nprint(len(set(vis)))","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:07:43.991262Z","iopub.execute_input":"2025-12-21T13:07:43.992022Z","iopub.status.idle":"2025-12-21T13:07:44.245108Z","shell.execute_reply.started":"2025-12-21T13:07:43.991988Z","shell.execute_reply":"2025-12-21T13:07:44.243950Z"}},"outputs":[{"name":"stdout","text":"500000\n345687\n","output_type":"stream"}],"execution_count":204},{"cell_type":"code","source":"num_unique_pairs = len(set(zip(ens, vis)))\nprint(num_unique_pairs)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:07:44.246134Z","iopub.execute_input":"2025-12-21T13:07:44.246407Z","iopub.status.idle":"2025-12-21T13:07:44.688661Z","shell.execute_reply.started":"2025-12-21T13:07:44.246374Z","shell.execute_reply":"2025-12-21T13:07:44.687351Z"}},"outputs":[{"name":"stdout","text":"348224\n","output_type":"stream"}],"execution_count":205},{"cell_type":"markdown","source":"# Normalize single text","metadata":{}},{"cell_type":"code","source":"import re\n\ndef normalize(text: str) -> str:\n    text = text.strip()\n    replace_map = {\n        '–':'-', '—':'-', '−':'-', '﹣':'-',\n        '':'≥', '':'≤',\n        '∕':'/', '／':'/',\n        '＝':'=',\n        '＋':'+',\n        '％':'%',\n        '±':'±',\n        '‘':\"'\", '’':\"'\",\n        '“':'\"', '”':'\"',\n    }\n    for k, v in replace_map.items():\n        text = text.replace(k, v)\n    text = re.sub(r'\\s+%', '%', text)\n    text = re.sub(r'\\s*/\\s*', '/', text)\n    text = re.sub(r'\\s*-\\s*', '-', text)\n    for symbol in ['<', '>', '=', '±', '+', '≥', '≤']:\n        text = re.sub(r'\\s*{}\\s*'.format(re.escape(symbol)), f' {symbol} ', text)\n\n    def merge_numbers_only(match):\n        s = match.group(0)\n        return s.replace(' ', '')\n    text = re.sub(r'\\b\\d[\\d\\s/.,%]*\\d\\b', merge_numbers_only, text)\n\n    text = re.sub(r'([.,:?!])(?=[A-Za-zÀ-ÖØ-öø-ÿ])', r'\\1 ', text)\n    text = re.sub(r'\\s+', ' ', text).strip()\n    text = re.sub(r'(\\d),\\s*(\\d)', r'\\1,\\2', text)\n    text = re.sub(r'(\\d)([.,])\\s*(\\d)', r'\\1\\2\\3', text)\n    return text\n\ns = 'Kết quả:So sánh nhóm TAP (n+ 30) và nhóm chứng (n= 30), 1. 4/2 3 trung vị điểm VAS khi nghỉ và vận động của nhóm chứng cao hơn so với nhóm TAP.'\nprint(normalize(s))","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:07:44.689982Z","iopub.execute_input":"2025-12-21T13:07:44.690389Z","iopub.status.idle":"2025-12-21T13:07:44.712691Z","shell.execute_reply.started":"2025-12-21T13:07:44.690351Z","shell.execute_reply":"2025-12-21T13:07:44.711729Z"}},"outputs":[{"name":"stdout","text":"Kết quả: So sánh nhóm TAP (n + 30) và nhóm chứng (n = 30), 1.4/23 trung vị điểm VAS khi nghỉ và vận động của nhóm chứng cao hơn so với nhóm TAP.\n","output_type":"stream"}],"execution_count":206},{"cell_type":"code","source":"ens = [normalize(en) for en in ens]\nvis = [normalize(vi) for vi in vis]","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:07:44.713861Z","iopub.execute_input":"2025-12-21T13:07:44.714139Z","iopub.status.idle":"2025-12-21T13:09:11.649698Z","shell.execute_reply.started":"2025-12-21T13:07:44.714105Z","shell.execute_reply":"2025-12-21T13:09:11.648891Z"}},"outputs":[],"execution_count":207},{"cell_type":"markdown","source":"# Normalize pair of texts","metadata":{}},{"cell_type":"code","source":"def strip_special_edge(s):\n    prefix = re.match(r'^[^\\w\\d]+', s)\n    suffix = re.search(r'[^\\w\\d]+$', s)\n    pre = prefix.group(0) if prefix else ''\n    suf = suffix.group(0) if suffix else ''\n    core = s[len(pre):len(s)-len(suf)] if suf else s[len(pre):]\n    return pre, core, suf\n    \ndef norm_pair(en: str, vi: str):\n    bullet_pattern = r'^([a-zA-Z][\\.\\)])|-(?!\\d)'\n\n    en_match = re.match(bullet_pattern, en)\n    vi_match = re.match(bullet_pattern, vi)\n    if en_match and not vi_match:\n        bullet = en_match.group(0)\n        if bullet == '-':\n            vi = bullet + vi.lstrip('-').lstrip()\n        else:\n            vi = bullet + ' ' + vi\n    if vi_match and not en_match:\n        bullet = vi_match.group(0)\n        if bullet == '-':\n            en = bullet + en.lstrip('-').lstrip()\n        else:\n            en = bullet + ' ' + en\n\n    en_pre, en_core, en_suf = strip_special_edge(en)\n    vi_pre, vi_core, vi_suf = strip_special_edge(vi)\n    \n    if en_pre != vi_pre:\n        en_pre = ''\n        vi_pre = ''\n    \n    if en_suf != vi_suf:\n        en_suf = ''\n        vi_suf = ''\n    \n    en_words = en_core.split()\n    vi_words = vi_core.split()\n    if en_words and en_words[0].replace('.', '').replace(',', '').isdigit():\n        if vi_core.find(en_words[0]) == -1:\n            en_words = en_words[1:]\n    if vi_words and vi_words[0].replace('.', '').replace(',', '').isdigit():\n        if en_core.find(vi_words[0]) == -1:\n            vi_words = vi_words[1:]\n    \n    en_core = ' '.join(en_words)\n    vi_core = ' '.join(vi_words)\n\n    en = en_pre + en_core + en_suf\n    vi = vi_pre + vi_core + vi_suf\n    return en, vi\n\nprint(norm_pair('x) ok.', 'ok!'))\nprint(norm_pair('- Hello!', '- Hi!)'))\nprint(norm_pair('a. test', 'test'))\nprint(norm_pair('a) one', 'b) one'))","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:11.650742Z","iopub.execute_input":"2025-12-21T13:09:11.651013Z","iopub.status.idle":"2025-12-21T13:09:11.698318Z","shell.execute_reply.started":"2025-12-21T13:09:11.650990Z","shell.execute_reply":"2025-12-21T13:09:11.697366Z"}},"outputs":[{"name":"stdout","text":"('x) ok', 'x) ok')\n('- Hello', '- Hi')\n('a. test', 'a. test')\n('a) one', 'b) one')\n","output_type":"stream"}],"execution_count":208},{"cell_type":"code","source":"ens_norm = []\nvis_norm = []\n\nfor en, vi in zip(ens, vis):\n    en_new, vi_new = norm_pair(en, vi)\n    ens_norm.append(en_new)\n    vis_norm.append(vi_new)\n\nens = ens_norm\nvis = vis_norm","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:11.699883Z","iopub.execute_input":"2025-12-21T13:09:11.700163Z","iopub.status.idle":"2025-12-21T13:09:23.881414Z","shell.execute_reply.started":"2025-12-21T13:09:11.700139Z","shell.execute_reply":"2025-12-21T13:09:23.880153Z"}},"outputs":[],"execution_count":209},{"cell_type":"markdown","source":"# Remove duplicate","metadata":{}},{"cell_type":"code","source":"def dedup_pairs(ens, vis):\n    seen = set()\n    new_ens, new_vis = [], []\n\n    for en, vi in zip(ens, vis):\n        pair = (en, vi)\n        if pair not in seen:\n            seen.add(pair)\n            new_ens.append(en)\n            new_vis.append(vi)\n\n    return new_ens, new_vis\nens, vis = dedup_pairs(ens, vis)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:23.885316Z","iopub.execute_input":"2025-12-21T13:09:23.885670Z","iopub.status.idle":"2025-12-21T13:09:24.519616Z","shell.execute_reply.started":"2025-12-21T13:09:23.885641Z","shell.execute_reply":"2025-12-21T13:09:24.518528Z"}},"outputs":[],"execution_count":210},{"cell_type":"markdown","source":"# Remove samples that have more than 2 translation ","metadata":{}},{"cell_type":"code","source":"remove_ids = set()\n\nen2vi = {}\nfor i in range(len(ens)):\n    en = ens[i]\n    if en in en2vi:\n        en2vi[en].append(i)\n    else:\n        en2vi[en] = [i]\nfor en, vi_ids in en2vi.items():\n    if len(vi_ids) > 1:\n        remove_ids.update(vi_ids)\n\nvi2en = {}\nfor i in range(len(vis)):\n    vi = vis[i]\n    if vi in vi2en:\n        vi2en[vi].append(i)\n    else:\n        vi2en[vi] = [i]\nfor vi, en_ids in vi2en.items():\n    if len(en_ids) > 1:\n        remove_ids.update(en_ids)\n        \nlen(remove_ids)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:24.520789Z","iopub.execute_input":"2025-12-21T13:09:24.521086Z","iopub.status.idle":"2025-12-21T13:09:26.077383Z","shell.execute_reply.started":"2025-12-21T13:09:24.521050Z","shell.execute_reply":"2025-12-21T13:09:26.076441Z"}},"outputs":[{"execution_count":211,"output_type":"execute_result","data":{"text/plain":"6831"},"metadata":{}}],"execution_count":211},{"cell_type":"code","source":"ens = [s for i, s in enumerate(ens) if i not in remove_ids]\nvis = [s for i, s in enumerate(vis) if i not in remove_ids]","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:26.078650Z","iopub.execute_input":"2025-12-21T13:09:26.079721Z","iopub.status.idle":"2025-12-21T13:09:26.247156Z","shell.execute_reply.started":"2025-12-21T13:09:26.079690Z","shell.execute_reply":"2025-12-21T13:09:26.246378Z"}},"outputs":[],"execution_count":212},{"cell_type":"markdown","source":"# Remove sample that have only number in text","metadata":{}},{"cell_type":"code","source":"remove_ids = set()\nfor i, (en, vi) in enumerate(zip(ens, vis)):\n    if not re.search(r'[A-Za-z]', en) or not re.search(r'[A-Za-z]', vi):\n        remove_ids.add(i)\nlen(remove_ids)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:26.248202Z","iopub.execute_input":"2025-12-21T13:09:26.248525Z","iopub.status.idle":"2025-12-21T13:09:26.844035Z","shell.execute_reply.started":"2025-12-21T13:09:26.248489Z","shell.execute_reply":"2025-12-21T13:09:26.842792Z"}},"outputs":[{"execution_count":213,"output_type":"execute_result","data":{"text/plain":"29"},"metadata":{}}],"execution_count":213},{"cell_type":"code","source":"ens = [s for i, s in enumerate(ens) if i not in remove_ids]\nvis = [s for i, s in enumerate(vis) if i not in remove_ids]","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:26.845313Z","iopub.execute_input":"2025-12-21T13:09:26.845645Z","iopub.status.idle":"2025-12-21T13:09:27.013788Z","shell.execute_reply.started":"2025-12-21T13:09:26.845606Z","shell.execute_reply":"2025-12-21T13:09:27.012848Z"}},"outputs":[],"execution_count":214},{"cell_type":"markdown","source":"# Remove sample that have the large diffirence length in 2 text","metadata":{}},{"cell_type":"code","source":"import matplotlib.pyplot as plt\n\nen_lens = [len(s.strip().split()) for s in ens]\nvi_lens = [len(s.strip().split()) for s in vis]\n\nplt.figure(figsize=(10,5))\nplt.hist(en_lens, bins=50, alpha=0.5, label='EN', color='blue')\nplt.hist(vi_lens, bins=50, alpha=0.5, label='VI', color='orange')\nplt.xlabel('Number of words')\nplt.ylabel('Number of samples')\nplt.title('Word count distribution of EN and VI sentences')\nplt.legend()\nplt.show()\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:27.014903Z","iopub.execute_input":"2025-12-21T13:09:27.015187Z","iopub.status.idle":"2025-12-21T13:09:30.363588Z","shell.execute_reply.started":"2025-12-21T13:09:27.015153Z","shell.execute_reply":"2025-12-21T13:09:30.362578Z"}},"outputs":[{"output_type":"display_data","data":{"text/plain":"<Figure size 1000x500 with 1 Axes>","image/png":"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\n"},"metadata":{}}],"execution_count":215},{"cell_type":"code","source":"import matplotlib.pyplot as plt\n\nen_lens = [len(s.strip().split()) for s in ens]\nvi_lens = [len(s.strip().split()) for s in vis]\n\ndiff_lens = [vi - en for vi, en in zip(vi_lens, en_lens)]\n\nplt.figure(figsize=(10,5))\nplt.hist(diff_lens, bins=50, color='green', alpha=0.7)\nplt.xlabel('Word count difference (VI - EN)')\nplt.ylabel('Number of samples')\nplt.title('Distribution of word count difference between VI and EN')\nplt.axvline(0, color='red', linestyle='--', label='No difference')\nplt.legend()\nplt.show()\n","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:30.364692Z","iopub.execute_input":"2025-12-21T13:09:30.365037Z","iopub.status.idle":"2025-12-21T13:09:32.881794Z","shell.execute_reply.started":"2025-12-21T13:09:30.365005Z","shell.execute_reply":"2025-12-21T13:09:32.880934Z"}},"outputs":[{"output_type":"display_data","data":{"text/plain":"<Figure size 1000x500 with 1 Axes>","image/png":"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\n"},"metadata":{}}],"execution_count":216},{"cell_type":"code","source":"remove_ids = set()\nfor i, (en, vi) in enumerate(zip(ens, vis)):\n    en_len = len(en.strip().split())\n    vi_len = len(vi.strip().split())\n    \n    if en_len == 0 or vi_len == 0:\n        remove_ids.add(i)\n        continue\n    \n    if abs(vi_len - en_len) > 50:\n        remove_ids.add(i)\n        continue\n    ratio = max(vi_len / en_len, en_len / vi_len)\n    if ratio >= 3.0:\n        remove_ids.add(i)\n\nlen(remove_ids)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:32.883068Z","iopub.execute_input":"2025-12-21T13:09:32.883498Z","iopub.status.idle":"2025-12-21T13:09:34.879753Z","shell.execute_reply.started":"2025-12-21T13:09:32.883462Z","shell.execute_reply":"2025-12-21T13:09:34.878658Z"}},"outputs":[{"execution_count":217,"output_type":"execute_result","data":{"text/plain":"3149"},"metadata":{}}],"execution_count":217},{"cell_type":"code","source":"ens = [s for i, s in enumerate(ens) if i not in remove_ids]\nvis = [s for i, s in enumerate(vis) if i not in remove_ids]","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:34.881281Z","iopub.execute_input":"2025-12-21T13:09:34.881596Z","iopub.status.idle":"2025-12-21T13:09:35.046717Z","shell.execute_reply.started":"2025-12-21T13:09:34.881570Z","shell.execute_reply":"2025-12-21T13:09:35.045629Z"}},"outputs":[],"execution_count":218},{"cell_type":"markdown","source":"# Remove sample that the one is a part of the rest when remove space","metadata":{}},{"cell_type":"code","source":"remove_ids = set()\nfor i, (en, vi) in enumerate(zip(ens, vis)):\n    if en == vi:\n        continue\n    en_no_space = en.replace(' ', '')\n    vi_no_space = vi.replace(' ', '')\n    if en_no_space in vi_no_space or vi_no_space in en_no_space:\n        remove_ids.add(i)\nlen(remove_ids)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:35.047892Z","iopub.execute_input":"2025-12-21T13:09:35.048153Z","iopub.status.idle":"2025-12-21T13:09:36.120743Z","shell.execute_reply.started":"2025-12-21T13:09:35.048129Z","shell.execute_reply":"2025-12-21T13:09:36.120011Z"}},"outputs":[{"execution_count":219,"output_type":"execute_result","data":{"text/plain":"82"},"metadata":{}}],"execution_count":219},{"cell_type":"code","source":"ens = [s for i, s in enumerate(ens) if i not in remove_ids]\nvis = [s for i, s in enumerate(vis) if i not in remove_ids]","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:36.121645Z","iopub.execute_input":"2025-12-21T13:09:36.121942Z","iopub.status.idle":"2025-12-21T13:09:36.283081Z","shell.execute_reply.started":"2025-12-21T13:09:36.121918Z","shell.execute_reply":"2025-12-21T13:09:36.281938Z"}},"outputs":[],"execution_count":220},{"cell_type":"markdown","source":"# Remove sample that lower one is a part of lower rest","metadata":{}},{"cell_type":"code","source":"remove_ids = set()\nfor i, (en, vi) in enumerate(zip(ens, vis)):\n    en_lower = en.lower()\n    vi_lower = vi.lower()\n    if en_lower in vi_lower or vi_lower in en_lower:\n        remove_ids.add(i)\nlen(remove_ids)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:36.284355Z","iopub.execute_input":"2025-12-21T13:09:36.284628Z","iopub.status.idle":"2025-12-21T13:09:37.121778Z","shell.execute_reply.started":"2025-12-21T13:09:36.284604Z","shell.execute_reply":"2025-12-21T13:09:37.120641Z"}},"outputs":[{"execution_count":221,"output_type":"execute_result","data":{"text/plain":"218"},"metadata":{}}],"execution_count":221},{"cell_type":"code","source":"ens = [s for i, s in enumerate(ens) if i not in remove_ids]\nvis = [s for i, s in enumerate(vis) if i not in remove_ids]","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:37.123248Z","iopub.execute_input":"2025-12-21T13:09:37.123705Z","iopub.status.idle":"2025-12-21T13:09:37.291763Z","shell.execute_reply.started":"2025-12-21T13:09:37.123677Z","shell.execute_reply":"2025-12-21T13:09:37.290897Z"}},"outputs":[],"execution_count":222},{"cell_type":"markdown","source":"# Handle remove some sample that may be noise","metadata":{}},{"cell_type":"code","source":"for i, (en, vi) in enumerate(zip(ens, vis)):\n    if en == vi:\n        continue\n    if len(en.split()) <= 3 or len(vi.split()) <= 3:\n        print('-' * 50)\n        print(i)\n        print(en)\n        print(vi)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:09:37.292710Z","iopub.execute_input":"2025-12-21T13:09:37.293120Z","iopub.status.idle":"2025-12-21T13:09:39.126786Z","shell.execute_reply.started":"2025-12-21T13:09:37.293076Z","shell.execute_reply":"2025-12-21T13:09:39.125989Z"}},"outputs":[{"name":"stdout","text":"--------------------------------------------------\n221\nCase report.\nMô tả ca bệnh.\n--------------------------------------------------\n1854\nAdults 69.8%).\nNgười lớn 69,8%).\n--------------------------------------------------\n2304\nMen was 40%.\nNam giới chiếm 40%.\n--------------------------------------------------\n3247\nCross-sectional, retrospective description.\nPhương pháp: mô tả cắt ngang, hồi cứu.\n--------------------------------------------------\n3895\nand Pseudomonas spp.\nVà Pseudomonas spp.\n--------------------------------------------------\n4454\nRefined with n-buthanol.\nTinh chế bằng n-buthanol.\n--------------------------------------------------\n4749\nSample size: 349.\nSố khách thể: 349.\n--------------------------------------------------\n5006\nCó 82,6% neutropenia.\nCó 82,6% giảm bạch cầu hạt.\n--------------------------------------------------\n5711\nMortality is 46,7%.\nTỷ lệ tử vong là 46,7%.\n--------------------------------------------------\n6774\nby DMSO.\nbằng DMSO được tiến hành.\n--------------------------------------------------\n7430\nRetrospective cross-sectional description.\nHồi cứu mô tà cắt ngang.\n--------------------------------------------------\n7471\nAcute adrenal insufficiency\nCơn suy thượng thận cấp\n--------------------------------------------------\n7521\nMale/female ratio: 1.4.\nTỷ lệ nam/nữ: 1,4.\n--------------------------------------------------\n7684\nby ultrasound-assisted method.\nvới sự hỗ trợ của sóng siêu âm.\n--------------------------------------------------\n7907\nMale/female ratio: 3.83.\nTỷ lệ bệnh theo giới nam/nữ: 3,83.\n--------------------------------------------------\n9095\nIntraoperative complications were 15%.\nTai biến 15%.\n--------------------------------------------------\n9109\ngroup (32.2 ± 2.5 pg/mg).\n± 2,5 pg/mg).\n--------------------------------------------------\n9964\nHormones and health\nHormon và sức khoẻ\n--------------------------------------------------\n10327\nHibiscus plant\nCây Cà gai leo\n--------------------------------------------------\n10598\nAllospondias lakonensis\nCây Giâu gia xoan\n--------------------------------------------------\n10919\nTraffic accidents: 65.9%.\nTai nạn giao thông 65,9%.\n--------------------------------------------------\n11034\n96.8% were male\nNam chiếm 96,8\n--------------------------------------------------\n11044\nComplications: Sepsis (3/18)-16.7%.\nBiến chứng nặng: nhiễm khuẩn huyết-15.8%.\n--------------------------------------------------\n11087\nMale/Female ratio: 1.50/1.\nTỷ lệ nam/nữ: 1,50/1.\n--------------------------------------------------\n12683\nObjective: (1).\nMục tiêu nghiên cứu: (1).\n--------------------------------------------------\n13445\nLeft pleural drainage.\nDẫn lưu màng phổi trái.\n--------------------------------------------------\n13499\nDiabetes and Covid-19\nBệnh đái tháo đường và Covid-19\n--------------------------------------------------\n13926\nMethods: Controlled intervention.\nPhương pháp: Can thiệp có đối chứng.\n--------------------------------------------------\n13972\nMethod: Cohort study.\nPhương pháp nghiên cứu: nghiên cứu can thiệp.\n--------------------------------------------------\n14234\nMethods: Describe retrospective;\nPhương pháp: Mô tả hồi cứu;\n--------------------------------------------------\n14304\nHope & Sleep\nHy vọng & giấc ngủ\n--------------------------------------------------\n14520\nFlu\nBệnh cúm\n--------------------------------------------------\n15306\n(P < 0.05).\n(P < 0,05).\n--------------------------------------------------\n15738\nObjectives: 1).\nMục tiêu nghiên cứu: 1).\n--------------------------------------------------\n15842\nAmiodarone induced thyrotoxicosis\nCường giáp do dùng amiodarone\n--------------------------------------------------\n15918\nSmile is happiness\nCười là hạnh phúc\n--------------------------------------------------\n16115\nProcedures CPR (81.3%).\ncấp cứu ngừng tuần hoàn (81,3%).\n--------------------------------------------------\n16116\nRespiratory arrest (81.3%).\nCấp cứu ngừng hô hấp (81,3%).\n--------------------------------------------------\n16326\ninfection in humans.\ntrên người.\n--------------------------------------------------\n17072\nMen dominate 63,3%.\nGiới nam chiếm ưu thế 63,3%.\n--------------------------------------------------\n18282\nPomegranate\nCây Lựu\n--------------------------------------------------\n18689\nTime: Jannuary 2011-december 2016.\nThời gian: 2011-2016.\n--------------------------------------------------\n19223\nFemale accounted for 55.5%.\nNữ chiếm 55,5%.\n--------------------------------------------------\n19421\nAloe vera\nCây Lô hội\n--------------------------------------------------\n20327\nMale/female = 2.2/1.\nTỉ lệ nam/nữ = 2,2/1.\n--------------------------------------------------\n20363\nM485 culture broth.\nM 485.\n--------------------------------------------------\n20633\nPeriod: 1/2019-12/2020.\nThời gian: 1/2019-12/2020.\n--------------------------------------------------\n20965\nAnd 56.3%.\nVà 56,3%.\n--------------------------------------------------\n21270\npTNM is T2N0M0.\npTNM là T 2 N 0 M 0.\n--------------------------------------------------\n21963\nOut of hospital 28/9/2011.\nXuất viện 28/9/2011.\n--------------------------------------------------\n23676\nPsoriasis treatment drugs\nCác thuốc điều trị bệnh vẩy nến\n--------------------------------------------------\n24329\nPatients: 31.\nBệnh nhân nghiên cứu: 31.\n--------------------------------------------------\n25004\n762E: 3 cases.\n762 E: 3 ca.\n--------------------------------------------------\n25016\n775C: 1 case.\n775 C: 1 ca.\n--------------------------------------------------\n25302\nHyperthyroidism during Pregnancy\nCường giáp trong thai kì\n--------------------------------------------------\n25349\n96.7% were male\nNam chiếm 97,6\n--------------------------------------------------\n25429\nComparative intervention study.\nNghiên cứu can thiệp có so sánh.\n--------------------------------------------------\n26562\nFerritine increased (97.1%).\nFerritine tăng (97,1%).\n--------------------------------------------------\n26793\nMethods: Case description.\nPhương pháp nghiên cứu: Mô tả ca bệnh.\n--------------------------------------------------\n28532\nReasonable calcium/phosphorus ratio.\nTỷ lệ canxi/phospho hợp lý.\n--------------------------------------------------\n28590\nand E coli.\nvà E. coli.\n--------------------------------------------------\n29224\nMethods: Systematic review.\nPhương pháp: Tổng quan hệ thống.\n--------------------------------------------------\n29295\n100% union, full range of motion\nLiền xương 100\n--------------------------------------------------\n29994\nOliv, family Orange (Rutaceae).\nhọ Cam (Rutaceae).\n--------------------------------------------------\n30095\nSmoking history 40,3%.\nTiền sử hút thuốc lá 40,3%.\n--------------------------------------------------\n30383\nEarly complications 27.3%.\nBiến chứng sớm 27,3%.\n--------------------------------------------------\n30973\nMaterials and method.\nĐối tượng-phương pháp.\n--------------------------------------------------\n31909\nCytology: 47.8% malignant.\nTế bào học: 47,8% ác tính.\n--------------------------------------------------\n32164\nVentilator patients 85.7%.\nBệnh nhân thở máy chiếm 85,7%.\n--------------------------------------------------\n32165\nPneumonia infection 83.3%.\nViêm phổi chiếm 83,3%.\n--------------------------------------------------\n32178\nMale 76.2%.\nNam giới chiếm 76,2%.\n--------------------------------------------------\n32255\nResults: Male/female: 1/1.5.\nKết quả: Tỉ lệ giới nam/nữ là 1/1,5.\n--------------------------------------------------\n33660\nMale/Female ratio 1.9.\nTỷ lệ nam/nữ 1,9.\n--------------------------------------------------\n34009\nat 1000 µg/mL.\nở 1000 µg/mL.\n--------------------------------------------------\n34167\nSimple insulin 11.7%.\nInsulin đơn thuần 11,7%.\n--------------------------------------------------\n34172\nUnacceptable level: 93.1%-20.0%.\nMức không chấp nhận: 93,1%-20,0%.\n--------------------------------------------------\n35031\nTraumatic brain injuries for 44.2%.\nCTSN chiếm 44,2%.\n--------------------------------------------------\n35066\nRNA Drugs\nNhóm thuốc RNA\n--------------------------------------------------\n36244\nInduction: Hypotension (70.5\nKhởi mê: Hạ huyết áp 70,5\n--------------------------------------------------\n36293\n(p < 0.05).\n(p < 0,05).\n--------------------------------------------------\n36557\nPreoperative radiotherapy 38.2%.\nXạ trị trước mổ 38,2%.\n--------------------------------------------------\n36560\nFistula anastomosis 3.9%.\nRò miệng nối 3,9%.\n--------------------------------------------------\n36562\nRecurrence rate 2.6%.\nTỷ lệ tái phát 2,6%.\n--------------------------------------------------\n37417\nThe Lactobacillus spp.\nTrong đó hoạt tính ức chế, Lactobacillus spp.\n--------------------------------------------------\n37579\nGreat Ginseng\nSâm đại hành\n--------------------------------------------------\n37760\nare scarce.\nchưa được tìm thấy nhiều.\n--------------------------------------------------\n37935\nThe male/female ratio was equal to 6.4/1.\nNam/nữ = 6,4/1.\n--------------------------------------------------\n38244\nAccident rate 0.7%.\nTỉ lệ tai biến 0,7%.\n--------------------------------------------------\n38918\nlobata (Merr.)\nSleum.)\n--------------------------------------------------\n41118\nSp 58.8/76.5.\nĐộ đặc hiệu 58,8/76,5.\n--------------------------------------------------\n41119\nAcc 75.3/89.0%.\nĐộ chính xác 75,3/89,0%.\n--------------------------------------------------\n41517\nSwallowing rate 91.7%.\nTỷ lệ nuốt nghẹn 91,7%.\n--------------------------------------------------\n43374\n60% bulging eyes.\n60% lồi mắt.\n--------------------------------------------------\n43900\nRetrospective, descriptive, cross-sectional.\nNghiên cứu hồi cứu, mô tả, cắt ngang.\n--------------------------------------------------\n43959\nAverage BMI: 28.5.\nTrung bình BMI: 28,5.\n--------------------------------------------------\n44085\nare from 0.011-0.021%.\ncó hàm lượng acid clorogenic trong khoảng 0,011-0,021%.\n--------------------------------------------------\n44148\nMale/Female = 1/1.\nNam/nữ = 1/1.\n--------------------------------------------------\n45971\nMethod: cross-sectional study;\nPhương pháp nghiên cứu mô tả cắt ngang;\n--------------------------------------------------\n46939\n97.63% successful operation\nTỷ lệ phẫu thuật thành công 97,36\n--------------------------------------------------\n47322\nComplications: Bleeding 3.1%.\nBiến chứng: Chảy máu: 3,1%.\n--------------------------------------------------\n48128\nKeywords: NSAIDs, outpatients.\nTừ khoá: NSAIDs, điều trị ngoại trú.\n--------------------------------------------------\n48251\nKeywords: Periodontitis.\nTừ khoá: Viêm quanh răng.\n--------------------------------------------------\n49319\nKeywords: Pancreaticoduodenectomy, lymphadenectomy.\nTừ khoá: Cắt khối tá tuỵ, vét hạch.\n--------------------------------------------------\n49450\nKeywords: Dermatophytosis, dermatophytes.\nTừ khoá: Nấm da, vi nấm sợi.\n--------------------------------------------------\n49638\nEspecially the Ps.\nĐặc biệt các Ps.\n--------------------------------------------------\n50007\nKeywords: Vitiligo, TNF-.\nTừ khoá: Bạch biến, TNF-.\n--------------------------------------------------\n50393\nBlood loss 45ml-50ml.\nLượng máu mất 45ml-50ml.\n--------------------------------------------------\n50404\nUrine residual 50ml-100ml.\nNước tiểu tồn dư 50ml-100ml.\n--------------------------------------------------\n50589\nKeywords: Neonatal septicaemia\nTừ khoá: Nhiễm khuẩn huyết sơ sinh\n--------------------------------------------------\n50617\nMale 34 (75.56%).\nNam 34 bệnh nhân (75,56%).\n--------------------------------------------------\n51006\nKeywords: Emurly, nurses.\nTừ khoá: Thấu cảm, điều dưỡng viên.\n--------------------------------------------------\n51470\nKeywords: Diabetes, hypoglycemia.\nTừ khoá: Đái tháo đường, hạ đường huyết.\n--------------------------------------------------\n51576\nKeywords: Enoxaparin, anticoagulant.\nTừ khoá: Enoxaparin, thuốc chống đông.\n--------------------------------------------------\n51933\nKeywords: Medulloblastoma, children.\nTừ khoá: U nguyên tuỷ bào, trẻ em.\n--------------------------------------------------\n52017\nKeywords: Procalcitonin, infection.\nTừ khoá: Procalcitonin, nhiễm khuẩn.\n--------------------------------------------------\n52284\nKeywords: Boerhaave's syndrome.\nTừ khoá: Bệnh lý thủng thực quản.\n--------------------------------------------------\n52329\nAtomic absorption spectroscopy.\nPhương pháp quang phổ hấp thụ nguyên tử.\n--------------------------------------------------\n52872\nKeywords: Covid-19, Coronavirus.\nTừ khoá: COVID-19, Coronavirus.\n--------------------------------------------------\n53004\nKeywords: Sepsis, S.\nTừ khoá: Nhiễm khuẩn huyết, Staphylococcus aureus.\n--------------------------------------------------\n53881\nCode EL10053.\nMã số EL 10053.\n--------------------------------------------------\n53902\nMen affected 61.15%.\nNam giới chiếm 66,15%.\n--------------------------------------------------\n55318\nKeywords: Poisoning, paracetamol\nTừ khoá: Ngộ độc cấp, paracetamol\n--------------------------------------------------\n55340\nlower limb injuries\nMức độ hẹp (PSV): < 1,5 là 63,9\n--------------------------------------------------\n55433\nHyponatremia: 39.7%.\nHạ natri máu: 39,7%.\n--------------------------------------------------\n55434\nHyperkalemia: 41.3%.\nTăng kali máu: 41,3%.\n--------------------------------------------------\n55869\nFemale/male: 1/2.4.\nTỉ lệ nam/nữ: 2,4/1.\n--------------------------------------------------\n56000\nDeaths: 3,5%.\nTử vong: 3,5%.\n--------------------------------------------------\n56001\nVascular lesion: 0,8%.\nVết thương mạch: 0,8%.\n--------------------------------------------------\n56327\nKeyword: Atrophy, Dysplasia.\nTừ khoá: Viêm teo, dị sản.\n--------------------------------------------------\n56331\nAge 40-60: 73.5\n73,5% bệnh nhân 40-60 tuổi\n--------------------------------------------------\n56420\nResults: Female/Male: 1.5/1.\nKết quả: Tỉ lệ nữ/nam: 1,5/1.\n--------------------------------------------------\n56421\nMean age 46.7.\nTuổi trung bình là 46,7 tuổi.\n--------------------------------------------------\n56508\n100% had dysphagia.\n100% có nuốt nghẹn.\n--------------------------------------------------\n56565\n64years: 251/100.000 habitants.\nNhóm > 64 tuổi: 251/100.000 dân.\n--------------------------------------------------\n56661\nKeywords: BTIKG tea\nTừ khoá: chè trĩ BTIKG\n--------------------------------------------------\n56696\nDyspnea: 64,7%.\nKhó thở: 64,7%.\n--------------------------------------------------\n56697\n60years: 37,3%,18-60: 62,7%.\nTuổi > 60: 37,3%,18-60: 62,7%.\n--------------------------------------------------\n56699\nVomit: 23,5%.\nNôn: 23,5%.\n--------------------------------------------------\n56700\nShock: 62,2%.\nSốc: 21,6%.\n--------------------------------------------------\n56736\nKeywords: Asthma, cytokines\nTừ khoá: Hen phế quản, cytokine\n--------------------------------------------------\n57127\nMales/females: 4,1/1.\nTỷ lệ nam/nữ: 4,1/1.\n--------------------------------------------------\n57134\nKeywords: stained teeth\nTừ khoá: răng nhiễm sắc\n--------------------------------------------------\n57500\nVSS increase (97.7%).\nVSS tăng (97,7%).\n--------------------------------------------------\n57552\nOpen operate: 3,9%.\nMở ngực: 3,9%.\n--------------------------------------------------\n57736\nKeywords: patient transferring.\nTừ khoá: vận chuyển, chuyển tuyến.\n--------------------------------------------------\n57758\nNo intervention-related death.\nKhông tử vong liên quan đến kỹ thuật.\n--------------------------------------------------\n57797\nDeaths: 3,9%.\nTử vong: 3,9%.\n--------------------------------------------------\n57798\nSequenlae: 22,4%.\nDi chứng: 22,4%.\n--------------------------------------------------\n57799\nMen/female = 2,5/1.\nTỷ lệ nam/nữ = 2,5/1.\n--------------------------------------------------\n57801\nalcoholic: 58,3%.\nUống rượu: 58,3%.\n--------------------------------------------------\n57803\nWork accidents: 10,1%.\nĐơn chấn thương: 70,6%.\n--------------------------------------------------\n57960\nRates male/remale: 1.33/1.\nTỉ lệ nam/nữ là: 1,33.\n--------------------------------------------------\n58092\nInpatient: 11.9 days.\nThời gian điều trị trung bình: 11.9 ngày.\n--------------------------------------------------\n58165\nKeywords: cochlear implant\nTừ khoá: điện cực ốc tai\n--------------------------------------------------\n58350\nGood outcome 99,35%.\nThành công 99,35%.\n--------------------------------------------------\n58971\nCharacteristic histopathology.\nĐặc điểm mô bệnh học.\n--------------------------------------------------\n59063\nEQ index 86,5%.\nChỉ số EQ 86,5%.\n--------------------------------------------------\n59377\nKeywords: fungi, enzyme.\nTừ khoá: Vi nấm, enzyme.\n--------------------------------------------------\n59381\n4-year disease events.\nBệnh diễn biến 4 năm nay.\n--------------------------------------------------\n59480\nMethods: Case series\nPhương pháp: Mô tả loạt ca (case series\n--------------------------------------------------\n59522\nResults: Female/Male: 1/2.\nKết quả: Tỉ lệ nữ/nam: 1/2.\n--------------------------------------------------\n59523\nMean age: 56.7.\nTuổi trung bình là 56,7.\n--------------------------------------------------\n59857\nKeywords: IRM, ACL\nTừ khoá: CHT, DCCT\n--------------------------------------------------\n59893\nKeywords: PCL, MRI\nTừ khoá: Dây chằng chéo sau, CHT\n--------------------------------------------------\n59915\nKey words: GIST.\nTừ khoá: U mô đệm đường tiêu hoá.\n--------------------------------------------------\n60106\nKeywords: Fillings, endodontics.\nTừ khoá: Trám răng, nội nha.\n--------------------------------------------------\n60898\nKeywords: Gallstoner sunrgery.\nTừ khoá: Phẫu thuật sỏi mật.\n--------------------------------------------------\n61626\nKeywords: familial, enterobiasis.\nTừ khoá: tính gia đình, giun kim.\n--------------------------------------------------\n62066\nKeywords: Sepsis, cytokines\nTừ khoá: Nhiễm khuẩn huyết, cytokines\n--------------------------------------------------\n62134\nSuccess rate: 99.3%.\nTỷ lệ thành công: 99,3%.\n--------------------------------------------------\n62255\n(15.03%), Streptococcus spp.\n(15,03%), Streptococcus spp.\n--------------------------------------------------\n62263\n(22.93%), Klebsiella spp.\n(22,93%), Klebsiella spp.\n--------------------------------------------------\n62611\nErectile dysfunction\nRối loạn cương\n--------------------------------------------------\n62750\nAnorexia, fatigue 1.0-3.2%.\nChán ăn mệt mỏi 1,0-3,2%.\n--------------------------------------------------\n62761\nRhabdomyolysis 0%.\nTiêu cơ 0%.\n--------------------------------------------------\n62762\nMuscle pain 1.0%.\nĐau cơ 1,0%.\n--------------------------------------------------\n62992\nDesign: case-control study.\nThiết kế nghiên cứu: Nghiên cứu bệnh chứng.\n--------------------------------------------------\n63421\nKeywords: Food safety.\nTừ khoá: Thức ăn đường phố.\n--------------------------------------------------\n63453\nComplete blood count.\nHuyết tuỷ đồ.\n--------------------------------------------------\n63454\nKaryotype test.\nXét nghiệm NST đồ.\n--------------------------------------------------\n63455\nReal time-PCR technique.\nRealtime PCR.\n--------------------------------------------------\n63834\nKeywords: Retroperitoneal tumor\nTừ khoá: Bướu sau phúc mạc\n--------------------------------------------------\n64166\nKeywords: refractive error\nTừ khoá: tật khúc xạ\n--------------------------------------------------\n64310\nCD56 appeared unusually.\nCó thể gặp CD 56.\n--------------------------------------------------\n65089\nAnalytical, prospective study.\nKhảo sát phân tích tiến cứu.\n--------------------------------------------------\n65561\nKeywords: hyperuricemia, gout\nTừ khoá: tăng acic uric máu, gút\n--------------------------------------------------\n66009\nKeywords: Intravenous injection\nTừ khoá: tiêm tĩnh mạch\n--------------------------------------------------\n66012\nMethods: Observe, describe.\nPhương pháp nghiên cứu: Quan sát mô tả.\n--------------------------------------------------\n66111\nKeywords: fungal infection.\nTừ khoá: nhiễm trùng do nấm.\n--------------------------------------------------\n66227\nClinical method: 1.\nPhương pháp cận lâm sàng: 1.\n--------------------------------------------------\n66300\nMale/Female ratio: 5.4.\nTỉ lệ nam/nữ: 5,4.\n--------------------------------------------------\n66375\nF. F H.\nF. H.\n--------------------------------------------------\n66515\nMethod: Retrospective method.\nĐối tượng-Phương pháp: Phương pháp hồi cứu.\n--------------------------------------------------\n66596\nFair: 6/27 (22,22%).\nKhá: 6/27 (22,22%).\n--------------------------------------------------\n66597\nAverage: 5/27 (18,52%).\nTrung bình: 5/27 (18,52%).\n--------------------------------------------------\n66598\nBad: 2/27 (7,41%).\nKém: 2/27 (7,41%).\n--------------------------------------------------\n66869\nSpecificity: 86\nmắt chính thị\n--------------------------------------------------\n67096\nFemale/man: 3/21.\nTỷ lệ nữ/nam: 3/21.\n--------------------------------------------------\n67282\nMortality: 7.6% (overal).\nTử vong 7,6% (chung) và 4,5% (quai).\n--------------------------------------------------\n67399\nRatiomale/female = 1.5.\nTỷ lệ nam/nữ = 1,5.\n--------------------------------------------------\n67442\nKeywords: Rhabdomyosarcoma.\nTừ khoá: Sarcôm cơ vân.\n--------------------------------------------------\n67731\nKeywords: galactosemia, diagnose.\nTừ khoá: galactosemia, rối loạn chuyển hoá.\n--------------------------------------------------\n67852\nPace maker.\nMáy tạo nhịp tạm thời.\n--------------------------------------------------\n68052\nKeywords: Choledochal cyst.\nTừ khoá: Nang ống mật chủ.\n--------------------------------------------------\n68386\nRespiratory depressing: 0\nTác dụng phụ ức chế hô hấp\n--------------------------------------------------\n68662\nCongenital diaphragmatic hernia\nThoát vị hoành bẩm sinh\n--------------------------------------------------\n68667\n17/26 (66%) survived\nTỷ lệ sống 66\n--------------------------------------------------\n68733\nNo intraoperative complication.\nKhông biến chứng trong mổ.\n--------------------------------------------------\n68983\nAuditory hallucinations 71.1%.\nRối loạn cảm giác tri giác 77,8%.\n--------------------------------------------------\n68984\nOutcomes: Schizophrenia: 62.2%.\nTiến triển: Tâm thần phân liệt 62,2%.\n--------------------------------------------------\n68986\nBipolar disorders: 4.4%.\nRối loạn lưỡng cực 4,4%.\n--------------------------------------------------\n68987\nChronic delusion: 2.2%.\nRối loạn hoang tưởng mãn tính 2,2%.\n--------------------------------------------------\n69170\nKeywords: surfactant, preterm\nTừ khoá: surfactant, trẻ sanh non\n--------------------------------------------------\n69230\nRecurrance rate: 13%.\nTỷ lệ tái phát 13%.\n--------------------------------------------------\n69251\nKeywords: Atrophic rhinitis\nTừ khoá: viêm mũi teo, trĩ mũi\n--------------------------------------------------\n69337\nSynthesis of mono-6-amino-6-deoxy-betacyclodextrin\nTổng hợp dẫn xuất mono-6-amino-6-deoxy-betacyclodextrin\n--------------------------------------------------\n69669\nMethod: retrospective cohort.\nPhương pháp nghiên cứu: đoàn hệ hồi cứu.\n--------------------------------------------------\n69814\n79, (mean 0.\n79, trung bình: 0.\n--------------------------------------------------\n70291\nKeywords: Thyroid carcinoma.\nTừ khoá: ung thư giáp.\n--------------------------------------------------\n70495\nMethods and results.\nPhuơng pháp nghiên cứu.\n--------------------------------------------------\n70545\nPostoperation was normal.\nQuá trình điều trị hậu phẫu ổn định.\n--------------------------------------------------\n70801\nKeywords: fascioliasis, ELISA\nTừ khoá: sán lá gan lớn, ELISA\n--------------------------------------------------\n71012\nObservation.\nBệnh án.\n--------------------------------------------------\n71462\nSystematic random sampling.\nChọn mẫu ngẫu nhiên hệ thống.\n--------------------------------------------------\n71717\nMale/female = 1.63.\nNam/nữ = 1,63.\n--------------------------------------------------\n72367\nThree-lobe leaf blades.\nPhiến lá thường chia 3 thuỳ.\n--------------------------------------------------\n72441\n229 men/114 women.\nKết quả:-229 Nam/114 Nữ.\n--------------------------------------------------\n72444\n-Maximum Frequency: 3.\n-Tần suất tán sỏi tối đa: 3.\n--------------------------------------------------\n72543\nSacral pressure sores\nLoét tỳ đè vùng cùng cụt\n--------------------------------------------------\n72548\nAge: 38-80.\nTuổi từ 38-80.\n--------------------------------------------------\n72905\nBackground: Lactobacillus spp.\nĐặt vấn đề: Lactobacillus spp.\n--------------------------------------------------\n72911\nConclusion: Lactobacillus spp.\nKết luận: Các vi khuẩn Lactobacillus spp.\n--------------------------------------------------\n72914\nKeywords: antibiotic resistance\nTừ khoá: kháng kháng sinh\n--------------------------------------------------\n73123\nKeywords: pain, HIV/AIDS\nTừ khoá: đau, HIV/AIDS\n--------------------------------------------------\n73296\nMethods: Community intervention.\nPhương pháp nghiên cứu: Can thiệp cộng đồng.\n--------------------------------------------------\n73357\nKeywords: Lumbar hernia.\nTừ khoá: Thoát vị tam giác thắt lưng.\n--------------------------------------------------\n73419\nPyogenic arthritis 10.8%.\nViêm khớp nhiễm khuẩn 10,8%.\n--------------------------------------------------\n73420\nOsteoporosis 10.6%.\nLoãng xương 10,6%.\n--------------------------------------------------\n73519\nKeywords: TOT, mini-invasive.\nTừ khoá: TOT, ít xâm lấn.\n--------------------------------------------------\n73652\n5 males.\nGiới nam 5 ca.\n--------------------------------------------------\n73816\nMortality 33.33\nTử vong 8 ca (33,33\n--------------------------------------------------\n73898\nKeywords: Gastroschisis.\nTừ khoá: Hở thành bụng.\n--------------------------------------------------\n74367\nKeywords: LASIK, monovision.\nTừ khoá: LASIK, thị giác một mắt.\n--------------------------------------------------\n74597\np = 0.388.\np = 0,388.\n--------------------------------------------------\n74787\nKeywords: tracheotomy\nTừ khoá: mở khí quản\n--------------------------------------------------\n75278\n(19.76%), Staphylococcus spp.\n(19,76%), Staphylococcus spp.\n--------------------------------------------------\n75279\n(18.71%), Klebsiella spp.\n(18,71%), Klebsiella spp.\n--------------------------------------------------\n75280\n(18.59%), Acinetobacter spp.\n(18,59%), Acinetobacter spp.\n--------------------------------------------------\n75281\n(12.59%), Pseudomonas spp.\n(12,59%), Pseudomonas spp.\n--------------------------------------------------\n75900\nKeywords: diabetes\nTừ khoá: đái tháo đường\n--------------------------------------------------\n76520\nResearch Methods: description.\nPhương pháp nghiên cứu: mô tả dọc.\n--------------------------------------------------\n76765\nwere dominant.\ncao nhất.\n--------------------------------------------------\n76803\nAverage operative time was 26.2 ± 0,5 min.\n± 0,5 phút.\n--------------------------------------------------\n76937\nand no T1.\nKhông có TH nào T 1.\n--------------------------------------------------\n77042\n(39.9%), Klebsiella spp.\n(39,9%), Klebsiella spp.\n--------------------------------------------------\n77043\n(18.02%), Acinetobacter spp.\n(18,02%), Acinetobacter spp.\n--------------------------------------------------\n77044\n(13.38%), Staphylococcus spp.\n(13,38%), Staphylococcus spp.\n--------------------------------------------------\n77045\n(7.59%), Enterobacter spp.\n(7,59%), Enterobacter spp.\n--------------------------------------------------\n77053\nKeywords: ureteropelvic junction\nTừ khoá: hẹp khúc nối bể thận-niệu quản\n--------------------------------------------------\n77586\nMale/female = 1.96.\nTỷ lệ nam/nữ = 1,96.\n--------------------------------------------------\n77870\nMethod\nHCM\n--------------------------------------------------\n77887\nKeywords: diarrhea, norovirus\nTừ khoá: tiêu chảy cấp, norovirus\n--------------------------------------------------\n77900\nKeywords: Fixed, mobile.\nTừ khoá: Cố định, xoay.\n--------------------------------------------------\n77904\nMale/female: 3/1.\nNam/nữ là 3/1.\n--------------------------------------------------\n78101\n-Analytic Cross-sectional study.\n-Phương pháp cắt ngang phân tích.\n--------------------------------------------------\n78171\nCorolla 2-lipped 4/1.\nTràng chia 2 môi 4/1.\n--------------------------------------------------\n78180\nLeaves opposite, simple.\nLá đơn, mọc đối chéo chữ thập.\n--------------------------------------------------\n78233\nBacground: Bifidobacterium spp.\nĐặt vấn đề: Bifidobacterium spp.\n--------------------------------------------------\n78248\nin probiotic products\ntrong sản phẩm trợ sinh (probiotic\n--------------------------------------------------\n78516\nKeywords: Japanese encephalitis.\nTừ khoá: Viêm não Nhật Bản.\n--------------------------------------------------\n79417\nKeywords: tachycardia ablation\nTừ khoá: cắt đốt nhịp nhanh\n--------------------------------------------------\n79630\nKeywords: Carabelli's trait.\nTừ khoá: Đặc điểm Carabelli.\n--------------------------------------------------\n80152\nMortality rate was 6.8%.\nTử vong 6.8%.\n--------------------------------------------------\n80153\n-Methods: Cases series.\n-Phương pháp nghiên cứu: Mô tả loạt ca.\n--------------------------------------------------\n80262\nSplenectomy laparoscopic surgery\nPhẫu thuật nội soi cắt lách\n--------------------------------------------------\n80754\nKeywords: antibiotics, elderly\nTừ khoá: kháng sinh, người cao tuổi\n--------------------------------------------------\n80822\nComplication was few.\nTai biến do mổ không nhiều.\n--------------------------------------------------\n81173\nMean age: 56.18.\nTuổi trung bình là 56.18.\n--------------------------------------------------\n81316\nSpontaneous cerebellar hematomas\nMáu tụ tự phát ở tiểu não\n--------------------------------------------------\n81382\nKeywords: Catheter.\nTừ khoá: catheter.\n--------------------------------------------------\n82014\nKeywords: hypertension, osteoporosis\nTừ khoá: loãng xương, tăng huyết áp\n--------------------------------------------------\n82025\nCorolla bilabiate 2/3.\nHoa nhỏ, lưỡng tính, màu tím xanh.\n--------------------------------------------------\n82218\nKeywords: chordee.\nTừ khoá: cong dương vật.\n--------------------------------------------------\n82813\nKeywords: acne.\nTừ khoá: Mụn trứng cá.\n--------------------------------------------------\n82822\nKeywords: Cesarean Section.\nTừ khoá: Mổ lấy thai.\n--------------------------------------------------\n82862\nMortality was 1%.\nTỉ lệ tử vong 1%.\n--------------------------------------------------\n83655\nKeywords: renal angiomyolipomas\nTừ khoá: u mạch cơ mỡ thận\n--------------------------------------------------\n83674\nSingle randomized sample.\nChọn mẫu ngẫu nhiên đơn.\n--------------------------------------------------\n83696\nPost-myocardial infarction depression\nTrầm cảm sau nhồi máu cơ tim\n--------------------------------------------------\n83741\nOutcome measures.\nPhương tiện đánh giá.\n--------------------------------------------------\n83759\nInflorescences capitulum.\nCụm hoa đầu.\n--------------------------------------------------\n84024\nKeywords: Albuminuria, diabetes\nTừ khoá: Albumine niệu, đái tháo đường\n--------------------------------------------------\n84191\nKeywords: thoraco-lumbar injuries\nTừ khoá: Chấn thương cột sống\n--------------------------------------------------\n84194\nFemale 60.8%.\nNữ 60,8%.\n--------------------------------------------------\n84195\nCarotid lesions 63.2%.\nTổn thương động mạch cảnh 63,2%.\n--------------------------------------------------\n84312\nKeywords: Myasthenia gravis\nTừ khoá: Bệnh nhược cơ\n--------------------------------------------------\n85271\nKeywords: Multimodal analgesia.\nTừ khoá: Giảm đau đa mô thức.\n--------------------------------------------------\n85479\n91,7% were adenocarcinoma.\n91,7% là ung thư tế bào tuyến.\n--------------------------------------------------\n85549\nMale/female: 1.25/1.\nNam: nữ = 1,25:1.\n--------------------------------------------------\n85872\n(19 α Thal.\n(19 BN α Thal.\n--------------------------------------------------\n85973\nDeath rate was 21.4%.\nTử vong 21,4%.\n--------------------------------------------------\n86223\nMethods: Prospective descriptive.\nPhương pháp: Nghiên cứu tiến cứu mô tả.\n--------------------------------------------------\n86372\nStress and hypertension\nStress và tăng huyết áp\n--------------------------------------------------\n86928\nKeywords: Blood safety.\nTừ khoá: an toàn truyền máu.\n--------------------------------------------------\n87187\nP = 0.000).\nP = 0,000).\n--------------------------------------------------\n87210\nMale/Female: 5.6.\nTỉ lệ nam/nữ: 5,6.\n--------------------------------------------------\n87259\nGender: male/female: 1236/1124.\nGiới: Nam/Nữ: 1236/1124.\n--------------------------------------------------\n87372\nKeywords: Melorheostosis\nTừ khoá: bệnh nến xương\n--------------------------------------------------\n87471\nKeywords: Cold, Heat.\nTừ khoá: Hàn, Nhiệt.\n--------------------------------------------------\n87543\nFavorable surgical results.\nKết quả tốt chiếm tỷ lệ cao.\n--------------------------------------------------\n87549\nRadical resection 93,1%.\nPhẫu thuật lấy toàn bộ khối 93,2%.\n--------------------------------------------------\n87860\nFlorets many.\nHoa nhiều.\n--------------------------------------------------\n87886\nKeywords: Subarachnoid hemorrhage.\nTừ khoá: xuất huyết khoang dưới nhện.\n--------------------------------------------------\n88239\nMale/female ratio: 1.14.\nTỉ lệ nam/nữ: 1,14.\n--------------------------------------------------\n88647\nKeywords: IV extrasavation.\nTừ khoá: Thoát mạch.\n--------------------------------------------------\n89282\nKeywords: meniscus suture\nTừ khoá: khâu sụn chêm\n--------------------------------------------------\n89520\nKeywords: Antero-posterior, protrusive.\nTừ khoá: Chiều trước sau, nhô ra trước.\n--------------------------------------------------\n89549\nKeywords: Patient's satisfaction.\nTừ khoá: sự hài lòng của người bệnh.\n--------------------------------------------------\n89594\nwas 73%, spec.\nlà 73%, spec.\n--------------------------------------------------\n89600\nthe specificity (spec\nđộ chuyên (spec\n--------------------------------------------------\n89636\nSynthesis of nicorandil\nTổng hợp nicorandil\n--------------------------------------------------\n89846\nBlinking works well.\nKhả năng chớp mắt bình thường.\n--------------------------------------------------\n89853\nKeywords: testicular ectopia\nTừ khoá: Tinh hoàn lạc chỗ\n--------------------------------------------------\n90088\n88% was adenocarcinoma.\n88% lá cacinom tuyến.\n--------------------------------------------------\n90118\nMale/Female ratio: 1/1.08.\nTỉ lệ nam/nữ là: 1/1,08.\n--------------------------------------------------\n90392\nMethods: Empirical Research.\nPhương pháp nghiên cứu: Nghiên cứu thực nghiệm.\n--------------------------------------------------\n90619\nKeywords: Parathyroid hormone\nTừ khoá: Hormone tuyến cận giáp\n--------------------------------------------------\n90662\nBackground: Salmonella spp.\nĐặt vấn đề: Salmonella spp.\n--------------------------------------------------\n91038\nKeywords: ureteral stone\nTừ khoá: sỏi niệu quản\n--------------------------------------------------\n91182\nRelapse ratio 14.39%.\nTỉ lệ kháng peg-interferon là 0%.\n--------------------------------------------------\n91533\n+ Eyeball trauma.\n+ Tổn thương nhãn cầu đơn thuần.\n--------------------------------------------------\n91945\nVaginal cancer: epidemiology-diagnosis-treatment\nUng thư âm đạo: dịch tễ-chẩn đoán-điều trị\n--------------------------------------------------\n92032\nNo patient died.\nKhông có BN nào tử vong.\n--------------------------------------------------\n92791\n8μg/ml.\n8 ìg/ml.\n--------------------------------------------------\n92966\nIncremental peritoneal dialysis\nLọc màng bụng tăng tiến\n--------------------------------------------------\n93065\nMethod: Cross-sectional, descriptive.\nLoại hình nghiên cứu: cắt ngang, mô tả.\n--------------------------------------------------\n93353\nMean age: 39.4.\nTuổi trung bình là 39,4.\n--------------------------------------------------\n93368\nSmall tree.\nCây gỗ nhỏ.\n--------------------------------------------------\n93369\nInflorescences: Raceme.\nCụm hoa chùm.\n--------------------------------------------------\n93792\nKeywords: Thoracoscopic lobectomy\nTừ khoá: PTNSLN cắt thuỳ phổi\n--------------------------------------------------\n93796\nMean age: 46.5.\nTuổi trung bình là 46,5.\n--------------------------------------------------\n94052\nTumorous hemorrhage (13.16%).\nChảy máu trong u (13,16%).\n--------------------------------------------------\n94208\nKeywords: Metabolic syndrome\nTừ khoá: Hội chứng chuyển hoá\n--------------------------------------------------\n94347\nwas 16% (17/105).\nlà 16% (17/105).\n--------------------------------------------------\n94457\nKeywords: IV extrasavation\nTừ khoá: thoát mạch\n--------------------------------------------------\n94465\nKeywords: Aneurysms, embolization\nTừ khoá: phình mạch não, nút mạch\n--------------------------------------------------\n94481\nKeywords: Urachal cancer\nTừ khoá: Ung thư niệu rốn\n--------------------------------------------------\n94538\n51.1% are men\nNam giới chiếm 51,1\n--------------------------------------------------\n94811\nMortality was 47%.\nTử vong 47%.\n--------------------------------------------------\n94881\nKeywords: Laparoscopic splenectomy.\nTừ khoá: Nội soi cắt lách.\n--------------------------------------------------\n95305\nResults: the proportion of var.\nKết quả: var.\n--------------------------------------------------\n95357\nPoir., amiant, carragenan\namiant, carragenin\n--------------------------------------------------\n95430\nMalnutrition occupied 14.9%.\nSuy dinh dưỡng chiếm 14,9%.\n--------------------------------------------------\n95831\nIn 3.\nTuổi trung bình là 52,6.\n--------------------------------------------------\n96130\nMale: 2 cases.\nNam: 2 trường hợp.\n--------------------------------------------------\n96327\nKeywords: emergency, transfer\nTừ khoá: chuyển tuyến, cấp cứu\n--------------------------------------------------\n96864\nKeywords: Mediastinal tumors.\nTừ khoá: Bướu trung thất.\n--------------------------------------------------\n97463\nKeywords: Rotavirus, diarrhea.\nTừ khoá: Rotavirus, bệnh tiêu chảy cấp.\n--------------------------------------------------\n97885\nNo postoperative complications.\nKhông có biến chứng hậu phẫu.\n--------------------------------------------------\n98187\nMortality was 1.85%.\nTử vong 1,85%.\n--------------------------------------------------\n98207\nKeywords: Extra-osseous osteosarcoma\nTừ khoá: Sarcôm xương ngoài xương\n--------------------------------------------------\n98855\nThe ability of drug resistance of Acinetobacter spp.\nNhóm Acinetobacter spp.\n--------------------------------------------------\n99200\nThis is benign.\nĐây là một tổn thương lành tính.\n--------------------------------------------------\n99466\nLeaf blade lanceolate.\nPhiến lá tam giác hẹp.\n--------------------------------------------------\n99471\nKeywords: tumor, presacral\nTừ khoá: u, khoang trước xương cùng\n--------------------------------------------------\n99570\nMale/female: 3.4/1.\nTỷ lệ nam/nữ: 3,4/1.\n--------------------------------------------------\n99987\nin dogs/cats, toxocariasis, children\ntrẻ em\n--------------------------------------------------\n99989\nwas 71% (137/139).\nlà 71% (137/139).\n--------------------------------------------------\n99997\nKeywords: gastroschisis\nTừ khoá: hở thành bụng\n--------------------------------------------------\n100300\nGender: male/female: 14/6.\nGiới: Nam/Nữ: 14/6.\n--------------------------------------------------\n100702\nKeywords: Cervical cancer.\nTừ khoá: Cổ tử cung, ung thư.\n--------------------------------------------------\n100942\nFemale/male = 1,5/1.\nNam/nữ = 1,5/1.\n--------------------------------------------------\n101138\n(36.31%), Klebsiella spp.\n(36,31%), Klebsiella spp.\n--------------------------------------------------\n101139\n(15.74%), Acinetobacter spp.\n(15,74%), Acinetobacter spp.\n--------------------------------------------------\n101140\n(12.48%), Staphylococcus spp.\n(12,48%), Staphylococcus spp.\n--------------------------------------------------\n101141\n(11.78%), and Pseudomonas spp.\n(11,78%), Pseudomonas spp.\n--------------------------------------------------\n101668\nKeywords: multiple myeloma\nTừ khoá: đa u tuỷ xương\n--------------------------------------------------\n101924\nNot satisfied: 0.6%.\nKhông hài lòng: 0,6%.\n--------------------------------------------------\n102170\nBesides, Enterobacter spp.\nNgoài ra, Enterobacter spp.\n--------------------------------------------------\n102431\nWomen are 54.1%.\nNữ chiếm 54,1%.\n--------------------------------------------------\n102440\nKeywords: International Classification of Diseases 10\nTừ khoá: ICD-10\n--------------------------------------------------\n103275\n-Male/female = 2.7/1.\n-Tỷ lệ nam/nữ = 2,7/1.\n--------------------------------------------------\n103373\nMortality was 1.4%.\nTỉ lệ tử vong là 1,4%.\n--------------------------------------------------\n104163\nComplications of parotidectomy\nBiến chứng phẫu thuật tuyến mang tai\n--------------------------------------------------\n104523\nClarity achieves 97.9%.\nTính rõ ràng đạt 97,9%.\n--------------------------------------------------\n104617\nPituitary abscess\nÁp-xe tuyến yên\n--------------------------------------------------\n104666\nP = 0.37).\np = 0,37).\n--------------------------------------------------\n104794\nminimus collected.\nminimus.\n--------------------------------------------------\n104808\nminimus and An.\nminimus và An.\n--------------------------------------------------\n104925\nKeywords: Snodgrass technique\nTừ khoá: kỹ thuật Snodgrass\n--------------------------------------------------\n104985\nMortality rate: 2.0%.\nTỷ lệ tử vong: 2,0%.\n--------------------------------------------------\n105324\nWeight loss of 10.3%.\nSút cân 10,3%.\n--------------------------------------------------\n105612\n(6.84%), Pseudomonas spp.\n(6,84%), Pseudomonas spp.\n--------------------------------------------------\n106063\nKeywords: Obesity.\nTừ khoá: Bệnh béo phì.\n--------------------------------------------------\n106064\nAnesthesia\nGây mê\n--------------------------------------------------\n106136\nWomen is 67.6%.\nTỷ lệ nữ là 67,6%.\n--------------------------------------------------\n106281\ninfamily Caryophyllaceae\nthuộc họ Cẩm chướng (Caryophyllaceae\n--------------------------------------------------\n106320\n(18.22%); Pseudomonas spp.\n(18,22%); Pseudomonas spp.\n--------------------------------------------------\n106325\n(23.26%), Enterobacter spp.\n(23,26%), Enterobacter spp.\n--------------------------------------------------\n106337\nKeywords: tympanogram.\nTừ khoá: Nhĩ lượng đồ.\n--------------------------------------------------\n106417\nKeywords: shock\nTừ khoá: sốc\n--------------------------------------------------\n106756\nResults: Age: 60-70.\nKết quả nghiên cứu: Tuổi trung bình: 60-70.\n--------------------------------------------------\n106758\nMedian PSA 20-50ng/ml.\nTrị số PSA/máu trung bình 20-50 ng/ml.\n--------------------------------------------------\n106787\nNo malaria parasites.\nKhông thấy KST sốt rét.\n--------------------------------------------------\n106928\nKeywords: vermiform appendix.\nTừ khoá: Ruột thừa.\n--------------------------------------------------\n107161\nMortality was 1.8%.\nTỉ lệ tử vong 1,8%.\n--------------------------------------------------\n107165\nKeywords: capillary electrophoresis\nTừ khoá: điện di mao quản\n--------------------------------------------------\n107649\nKeywords: ARV, children.\nTừ khoá: Điều trị ARV, trẻ em.\n--------------------------------------------------\n108129\nThe ratio of male: female was 1.7: 1.\nNam: nữ 1,7:1.\n--------------------------------------------------\n108258\nMethod: case description.\nPhương pháp nghiên cứu: mô tả trường hợp.\n--------------------------------------------------\n108347\nKeywords: meningioma, microsurgery\nTừ khoá: u màng não, vi phẫu thuật\n--------------------------------------------------\n108385\nDesign: Case series.\nPhương pháp nghiên cứu: Hàng loạt ca.\n--------------------------------------------------\n108696\nBackground: The Ae.\nĐặt vấn đề: Muỗi Ae.\n--------------------------------------------------\n108703\nResults: Ae.\nKết quả: Muỗi Ae.\n--------------------------------------------------\n108739\nComplications are acceptable.\nCác biến chứng có thể chấp nhận được.\n--------------------------------------------------\n108966\nKeywords: Incidents, errors.\nTừ khoá: Sự cố, sai sót.\n--------------------------------------------------\n109246\nKeywords: HIV: human immunodeficiency virus\nTừ khoá: HIV\n--------------------------------------------------\n109393\nKeywords: Septicemia, sepsis.\nTừ khoá: Nhiễm khuẩn huyết.\n--------------------------------------------------\n109532\nKeywords: flexible bronchoscopy\nTừ khoá: nội soi phế quản ống mềm\n--------------------------------------------------\n109567\nKeywords: fibro thecoma\nTừ khoá: bướu vỏ sợi bào\n--------------------------------------------------\n109729\nKeywords: newborn screening\nTừ khoá: tầm soát sơ sinh\n--------------------------------------------------\n109830\nMean age: 55.3.\nTuổi trung bình là 55,3.\n--------------------------------------------------\n109834\nKeywords: thoracoscopic lobectomy\nTừ khoá: PTNS cắt thuỳ phổi\n--------------------------------------------------\n109923\nCase series report.\nNghiên cứu mô tả hàng loạt ca.\n--------------------------------------------------\n109978\nKeywords: Pneumonia, eosinophil.\nTừ khoá: Viêm phổi kéo dài, eosinophil.\n--------------------------------------------------\n110304\nKeywords: Kasabach-Merritt\nTừ khoá: Kasabach-Merritt\n--------------------------------------------------\n110555\nOsteoporosis-causes and treatment\nLoãng xương: nguyên nhân và thuốc điều trị\n--------------------------------------------------\n110600\nKeywords: Umbilical catheter.\nTừ khoá: catheter rốn.\n--------------------------------------------------\n110629\nHypovolemic Shock 11.4%.\nSốc giảm thể tích 11,4%.\n--------------------------------------------------\n110630\nIonized Hypocalcemia 9.8%.\nGiảm canxi ion hoá máu 9,8%.\n--------------------------------------------------\n110809\naccounted for 93.6%.\nchiếm 93,6%.\n--------------------------------------------------\n111043\nMale/female: 54/24.\nNam/nữ: 54/24.\n--------------------------------------------------\n111323\nKeywords: Sepsic, Candidemia.\nTừ khoá: Nhiễm nấm huyết.\n--------------------------------------------------\n111682\nKeywords: ketogenic diet\nTừ khoá: chế độ ăn ketogenic\n--------------------------------------------------\n111887\n9/10 total occlusion.\n9/10 không có tồn dư túi phình.\n--------------------------------------------------\n111895\nSmall aneurysms 100%.\nKích thước nhỏ 100%.\n--------------------------------------------------\n112018\nKeywords: ventilator-associated pneumonia\nTừ khoá: viêm phổi thở máy\n--------------------------------------------------\n114055\nMortality was 8.\nTử vong 8 trường hợp.\n--------------------------------------------------\n114371\nKeywords: Renal salvage.\nTừ khoá: Bảo tồn thận.\n--------------------------------------------------\n114410\nKeywords: Lipid-lipoprotein disorders.\nTừ khoá: Rối loạn các thành phần lipi-lipoprotein.\n--------------------------------------------------\n114696\nMean age: 50ys.\nTuổi trung bình 50 tuổi.\n--------------------------------------------------\n114883\nKeywords: Gastric volvulus.\nTừ khoá: xoắn dạ dày.\n--------------------------------------------------\n115701\nor 7-14 Fr\nhoặc 7-14 Fr\n--------------------------------------------------\n115702\nfor 6 weeks.\nlưu trong 6 tuần lễ.\n--------------------------------------------------\n115984\nKeywords: Child feeding.\nTừ khoá: Ăn dặm.\n--------------------------------------------------\n115998\nPostoperative stroke control\nKiểm soát đột quỵ sau mổ\n--------------------------------------------------\n116002\nKeywords: postoperative stroke\nTừ khoá: đột quỵ sau mổ\n--------------------------------------------------\n116049\ncoli, and Acinetobacter.\ncoli, Acinetobacter.\n--------------------------------------------------\n116690\nKeywords: artesunate-pyronaridine, efficacy\nTừ khoá: artesunate-pyronaridine, hiệu lực\n--------------------------------------------------\n117769\nPancreatic head resection.\nCắt tuỵ tiết kiệm.\n--------------------------------------------------\n117943\nFungal pneumonia\nViêm phổi do nấm\n--------------------------------------------------\n117948\nby broncho-alveolar lavages.\nqua dịch rửa phế quản.\n--------------------------------------------------\n118069\nOne patient experieced a peforation (1,19%).\nThủng 1/84 (1,19%).\n--------------------------------------------------\n118916\nWomen is 67.2%.\nTỷ lệ nữ là 67,2%.\n--------------------------------------------------\n119169\nMethod: retrospective description.\nPhương pháp nghiên cứu: mô tả hồi cứu.\n--------------------------------------------------\n119502\nOther Candida spp.\nCác loài Candida spp.\n--------------------------------------------------\n119527\nPeriod: 01/10/2013-01/10/2016.\nThời gian nghiên cứu: 01/10/2013-01/10/2016.\n--------------------------------------------------\n119795\nKeywords: predicted formulas\nTừ khoá: công thức dự đoán\n--------------------------------------------------\n120013\nFor Kleb bacteria.\nĐối với vi khuẩn Kleb.\n--------------------------------------------------\n120107\n56.67% is male.\n56,67% là nam giới.\n--------------------------------------------------\n120111\nKeywords: jaundice, neonatal\nTừ khoá: vàng da, sơ sinh\n--------------------------------------------------\n120401\nInternal phloem present.\nLibe quanh tuỷ hiện diện.\n--------------------------------------------------\n120408\nInflorescences extra-axillary.\nCụm hoa ngoài nách lá.\n--------------------------------------------------\n120602\nMortality rate 2.9%.\nTỷ lệ tử vong: 2,9%.\n--------------------------------------------------\n120995\nKeywords: ovarian fibrothecomas.\nTừ khoá: bướu sợi vỏ bào.\n--------------------------------------------------\n121391\nKeywords: bronchial tree\nTừ khoá: cây phế quản\n--------------------------------------------------\n121500\nKeywords: Spinal tumors\nTừ khoá: U tuỷ\n--------------------------------------------------\n121899\nThe lactobacillus spp.\nTrong đó hoạt tính ức chế, lactobacillus spp.\n--------------------------------------------------\n122234\n12-week intervention program.\nChương trình can thiệp trong 12 tuần.\n--------------------------------------------------\n122504\nReduced T BUT.\nThời gian vỡ phim nước mắt giảm.\n--------------------------------------------------\n122810\nKeywords: Methadone, HIV\nTừ khoá: Methadone, HIV\n--------------------------------------------------\n122860\nSensitivity is 72.7%.\nĐộ nhạy là 72,7%.\n--------------------------------------------------\n122861\nSpecificity is 83.2%.\nĐộ đặc hiệu là 83,2%.\n--------------------------------------------------\n123135\nKeywords: acupuncture, pain\nTừ khoá: châm cứu, đau\n--------------------------------------------------\n123204\nPancreatogastrostomy was performed.\nNối thân tuỵ với mặt sau dạ dày.\n--------------------------------------------------\n123801\nKeywords: atopic dermatitis\nTừ khoá: viêm da cơ địa\n--------------------------------------------------\n124302\nBoys/girls ratio: 1.9/1.\nTỉ lệ nam/nữ là 1,9/1.\n--------------------------------------------------\n124339\nNo regurgitation.\nKhông trào ngược.\n--------------------------------------------------\n124401\n3 death (6.9%).\nTử vong 3 (6,9%).\n--------------------------------------------------\n124463\nSwiss Albino mice.\nChuột nhắt chủng Swiss albino.\n--------------------------------------------------\n124529\nKeywords: incompatible, injections\nTừ khoá: tương kỵ, thuốc tiêm\n--------------------------------------------------\n124677\naegypti and Ae.\nalbopictus và Ae.\n--------------------------------------------------\n124690\nOH-Orthostatic Hypotension\nHHATT-Hạ huyết áp tư thế\n--------------------------------------------------\n124921\nMean age: 64.\nTuổi TB: 64.\n--------------------------------------------------\n125060\nObiectives: 1.\nMục đích nghiên cứu: 1.\n--------------------------------------------------\n125394\nMortality is 22.6%.\nTỉ lệ tử vong 22,6%.\n--------------------------------------------------\n125438\nThe larvae of Ae.\nBọ gậy Ae.\n--------------------------------------------------\n125797\n(18.1%), Klebsiella spp.\n(18,1%), Klebsiella spp.\n--------------------------------------------------\n125798\n(14.58%), Staphylococcus spp.\n(14,58%), Staphylococcus spp.\n--------------------------------------------------\n125993\nRight attitude 74.7%.\nThái độ đúng 74,7%.\n--------------------------------------------------\n125994\nCorrect behavior 73.9%.\nHành vi đúng 73,9%.\n--------------------------------------------------\n126545\nKeywords: bladder diverticula\nTừ khoá: túi thừa bàng quang\n--------------------------------------------------\n127012\n40.7% of patients had infected with HIV.\n40,7% nhiễm HIV.\n--------------------------------------------------\n127671\nConclusion: The HP.\nKết luận: Tỉ lệ dương tính với HP.\n--------------------------------------------------\n127728\nKeywords: content\nTừ khoá: hài lòng\n--------------------------------------------------\n128053\nFungal infection: Candida.\nCandida trong nhiễm nấm huyết.\n--------------------------------------------------\n128315\nKeywords: dysphagia, dysphagia\nTừ khoá: rối loạn nuốt, đột quỵ\n--------------------------------------------------\n128943\nSelect convenience samples.\nChọn mẫu thuận tiện.\n--------------------------------------------------\n129242\nGood results 93.75%.\nKết quả tốt là 93,75%.\n--------------------------------------------------\n129246\nSterilization: 0.5%.\nTriệt sản: 0,5%.\n--------------------------------------------------\n129248\nContraception tablet: 11%.\nThuốc viên tránh thai: 11%.\n--------------------------------------------------\n129249\nComdom: 26.1%.\nBao cao su: 26,1%.\n--------------------------------------------------\n129551\nMean age: 57.5.\nTuổi trung bình là 57,5.\n--------------------------------------------------\n129691\nLate death: 0,7%.\nTỷ lệ tử vong muộn là 0,7%.\n--------------------------------------------------\n129769\nKeywords: unicoronal plagiocephaly\nTừ khoá: Dinh khớp sọ một bên\n--------------------------------------------------\n130357\ncontains coumarinic compounds.\ncó chứa thêm các hợp chất coumarin.\n--------------------------------------------------\n130459\nRatio female/male: 9/1.\nTỉ lệ Nữ/Nam là 9/1.\n--------------------------------------------------\n130501\nMortality is high.\nTỷ lệ tử vong cũng rất cao.\n--------------------------------------------------\n130883\nMethod: Cross-section, analysis.\nPhương pháp nghiên cứu: Cắt ngang, phân tích.\n--------------------------------------------------\n131061\n; T d.\n; T. d.\n--------------------------------------------------\n131062\nand T f.\nvà T. f.\n--------------------------------------------------\n131682\nClinical, retrospective research.\nNghiên cứu lâm sàng, phương pháp hồi cứu.\n--------------------------------------------------\n131766\nMaterial and Methods.\nChất liệu và phương pháp nghiên cứu.\n--------------------------------------------------\n131872\nKeywords: eGFR, out-patient.\nTừ khoá: Độ lọc cầu thận, ngoại trú.\n--------------------------------------------------\n132120\nPortal hypertension: 6%.\nTăng áp lực tĩnh mạch cữa: 6%.\n--------------------------------------------------\n132126\nRuptured tumors: 10%.\nBướu vỡ trước PT là 10%.\n--------------------------------------------------\n132127\nHospital mortality: 4\nThời gian mổ TB là 60 phút\n--------------------------------------------------\n132133\nAscites ( + ): 12%.\nBáng bụng: 12%.\n--------------------------------------------------\n132329\nMethods: case series\nPhương pháp: mô tả hàng loạt trường hợp\n--------------------------------------------------\n132590\nKeywords: primary hyperparathyroidism\nTừ khoá: Cường cận giáp nguyên phát\n--------------------------------------------------\n132778\nWaist/rump ratio was58.55%.\nTỉ số eo/mông cao là 58,55%.\n--------------------------------------------------\n132808\nKeywords: community-acquired pneumonia\nTừ khoá: viêm phổi cộng đồng\n--------------------------------------------------\n132885\nKeywords: Sudden deafness\nTừ khoá: Điếc đột ngột\n--------------------------------------------------\n132891\nRefractive error 93.4%.\nTật khúc xạ chiếm 93,4%.\n--------------------------------------------------\n133401\nEndoscopic esophageal stenting\nĐiều trị đặt stent kim loại thực quản\n--------------------------------------------------\n133462\nKeywords: frail, elderly\nTừ khoá: suy yếu, người cao tuổi\n--------------------------------------------------\n133486\nThrombocytosis was 32.28%.\nSố lượng tiểu cầu tăng chiếm 32,28%.\n--------------------------------------------------\n133570\nKeywords: reinkes edema\nTừ khoá: phù Reinke\n--------------------------------------------------\n134280\nKeywords: disease model\nTừ khoá: mô hình bệnh\n--------------------------------------------------\n134440\nLaparoscopic approach is OBJECTIVES.\nMỤC TIÊU.\n--------------------------------------------------\n134899\n60% male\nGiới nam 60\n--------------------------------------------------\n135477\nDysphasia Polyp 72.55%.\nPolyp loạn sản chiếm 72,55%.\n--------------------------------------------------\n135478\nCancer Polyp 9.8%.\nPolyp ung thư 9,8%.\n--------------------------------------------------\n135540\n(P = 0.016).\n(P = 0,016).\n--------------------------------------------------\n135547\nActive environmental sampling.\nLấy mẫu môi trường chủ động.\n--------------------------------------------------\n135723\nMale/female is 2/3.\nTỉ lệ nam/nữ là 2/3.\n--------------------------------------------------\n135787\nKeywords: osteoarthritis\nTừ khoá: thoái hoá khớp\n--------------------------------------------------\n136263\nSimple nephrectomy performed.\nCắt thận qua nội soi sau phúc mạc.\n--------------------------------------------------\n136420\nKeywords: Patient care.\nTừ khoá: Chăm sóc người bệnh.\n--------------------------------------------------\n136486\nHypertension: 53.7%.\nCao huyết áp: 53,7%.\n--------------------------------------------------\n136499\nMale/female: 3.5/1.\nTỷ lệ nam/nữ: 3,5/1.\n--------------------------------------------------\n136591\n5.1%, Acinetobacter spp.\n5,1%, Acinetobacter spp.\n--------------------------------------------------\n136802\nKeywords: C-section, rate.\nTừ khoá: Mổ lấy thai, tỉ lệ.\n--------------------------------------------------\n137055\nKeywords: Insulinoma, Hypoglycemia\nTừ khoá: Insulinoma, hạ đường huyết\n--------------------------------------------------\n137164\n(P < 0.0001).\n(p < 0,0001).\n--------------------------------------------------\n137463\nAcidosis 25%.\nToan máu 25%.\n--------------------------------------------------\n137469\nHospital death 17.9%.\nTử vong bệnh viện 17,9%.\n--------------------------------------------------\n137550\nNo complication occurs.\nÍt tai biến-biến chứng.\n--------------------------------------------------\n137551\nCost is markedy low.\nChi phí thấp.\n--------------------------------------------------\n137801\nKeywords: Breast milk.\nTừ khoá: Nuôi con bằng sữa mẹ.\n--------------------------------------------------\n138184\nSedimentation was high.\nTốc độ lắng máu tăng.\n--------------------------------------------------\n138264\nMethod: Flow cytometry.\nPhương pháp dòng chảy tế bào.\n--------------------------------------------------\n138877\nType IV: 7.7%.\nType IV: 7,7%.\n--------------------------------------------------\n138883\nType II: 46.1%.\nType II: 46,1%.\n--------------------------------------------------\n138884\nType IIIa: 17.9%.\nType IIIa: 17,9%.\n--------------------------------------------------\n138885\nType IIIb: 17.9%.\nType IIIb: 17,9%.\n--------------------------------------------------\n139174\nKeywords: epistaxis, nosebleed.\nTừ khoá: chảy máu mũi.\n--------------------------------------------------\n139461\nKeywords: Cirrhosis, coagulopathy-hemostasis.\nTừ khoá: Xơ gan, rối loạn đông-cầm máu.\n--------------------------------------------------\n139540\nNo operation dead.\nKhông có trường hợp nào bị tử vong.\n--------------------------------------------------\n139684\nis 55.4%.\nlà 55,4%.\n--------------------------------------------------\n139848\nKeywords: Suicide admitted.\nTừ khoá: Yếu tố xã hội tâm thần.\n--------------------------------------------------\n140258\nRatio female/male: 1.7/1.\nTỉ lệ Nữ/Nam là 1,7/1.\n--------------------------------------------------\n140454\nMortality is 12.3%.\nTử vong sau mổ 12,3%.\n--------------------------------------------------\n140604\nSynthesis of felodipine\nTổng hợp felodipin\n--------------------------------------------------\n140765\nKeywords: external fixator\nTừ khoá: cố định ngoài\n--------------------------------------------------\n141217\nKeywords: Geniposide, gardenoside\nTừ khoá: Geniposid, gardenosid\n--------------------------------------------------\n141256\nKeywords: Outpatient prescription.\nTừ khoá: Thuốc, kê toa.\n--------------------------------------------------\n141880\nLeast 133 patients\nKém 133 BN (35,95\n--------------------------------------------------\n142171\nKeywords: Pediatric polytrauma.\nTừ khoá: Đa chấn thương, trẻ em.\n--------------------------------------------------\n142300\nKeywords: Sella turcica\nTừ khoá: Hố yên\n--------------------------------------------------\n142407\nseed 3.\nHạt 3.\n--------------------------------------------------\n142623\nKeywords: persistent diarrhoea.\nTừ khoá: tiêu chảy kéo dài.\n--------------------------------------------------\n142883\nMethod: Description, retrospective.\nPhương pháp nghiên cứu: Mô tả, hồi cứu.\n--------------------------------------------------\n142892\nWomen 60.8%.\nNữ chiếm 60,8%.\n--------------------------------------------------\n142894\nHyperuricemia was 27.5%.\nTỉ lệ tăng acid uric huyết thanh 27,5%.\n--------------------------------------------------\n143219\nKeywords: Robotic procedures.\nTừ khoá: Phẫu thuật nội soi Robot.\n--------------------------------------------------\n143264\nKeywords: inguinal hernia\nTừ khoá: phẫu thuật phục hồi thành bẹn\n--------------------------------------------------\n143733\nLateral lid hooding.\nSa mi trên ở nửa ngoài.\n--------------------------------------------------\n144196\n-Conversion: 3 cases.\n-Chuyển mổ hở: 3 trường hợp.\n--------------------------------------------------\n144252\nFemales were 66.2%.\nGiới nữ 66,2%.\n--------------------------------------------------\n144253\nMales were 59.3%.\nGiới nam 59,3%.\n--------------------------------------------------\n144278\nInvasive basal layer (23%).\nDính nền (23%).\n--------------------------------------------------\n144424\nProspective, cross-sectional descriptive.\nNghiên cứu tiến cứu, cắt ngang mô tả.\n--------------------------------------------------\n144496\nKeywords: Branchial anomalies\nTừ khoá: bệnh lý khe mang\n--------------------------------------------------\n144731\nNo patient needed reoperation.\nNhi Dồng 1.\n--------------------------------------------------\n144819\nKeywords: MIH, Hypomineralization\nTừ khoá: MIH, kém khoán\n--------------------------------------------------\n145104\nKeywords: orthokerathology, myopia.\nTừ khoá: chỉnh hình giác mạc, cận thị.\n--------------------------------------------------\n145321\nMean age: 57.8.\nTuổi trung bình là 57,8.\n--------------------------------------------------\n145667\nSuccess percentage was of 80.6%.\nThành công 80,6%.\n--------------------------------------------------\n145971\nStudy time: 03/2019-12/2019.\nThời gian nghiên cứu: 03/2019-12/2019.\n--------------------------------------------------\n146016\nKeywords: malaria elimination\nTừ khoá: loại trừ sốt rét\n--------------------------------------------------\n146046\nKeywords: AmpC beta-lactamase\nTừ khoá: AmpC beta-lactamase\n--------------------------------------------------\n146146\nMethod: Control trial.\nPhương pháp: Nghiên cứu đối chứng.\n--------------------------------------------------\n146230\nTeeth were longitudinal sectioned.\nCắt dọc răng.\n--------------------------------------------------\n146326\nThe male to female ratio was 2/1\nNam/Nữ 2/1 (36/18\n--------------------------------------------------\n146556\nmortality = 0%.\nTỉ lệ tử vong = 0%.\n--------------------------------------------------\n146562\nMale/female = 2,33.\nTỉ lệ nam: nữ = 2,33.\n--------------------------------------------------\n146940\nKeywords: plantaris tendo\nTừ khoá: gân cơ gan chân\n--------------------------------------------------\n147122\nCancer and infection\nUng thư và bệnh nhiễm\n--------------------------------------------------\n147219\nblood at post-op).\nmáu sau mổ).\n--------------------------------------------------\n148016\nKeywork: Knowledge, practice\nTừ khoá: Kiến thức, thực hành\n--------------------------------------------------\n148160\nKeywords: bacteria, mastoidectomy.\nTừ khoá: vi trùng, phẫu thuật tai hở.\n--------------------------------------------------\n148254\nCodman's triangle (53.6%).\nTam giác Codman (53,6%).\n--------------------------------------------------\n148498\nKeywords: penile amputation\nTừ khoá: vết thương cắt cụt dương vật\n--------------------------------------------------\n148516\nKeys words: Hypospadias.\nTừ khoá: Lỗ đái lệch thấp.\n--------------------------------------------------\n148683\n: Small tree.\n: Thân gỗ nhỏ.\n--------------------------------------------------\n148685\nSolitary flower.\nHoa riêng lẻ.\n--------------------------------------------------\n148687\nCorolla polypetalous.\nCánh hoa rời.\n--------------------------------------------------\n148751\n1 died.\n1 ca tử vong.\n--------------------------------------------------\n148760\nKeywords: Overweight, obesity.\nTừ khoá: Thừa cân béo phì.\n--------------------------------------------------\n148864\nE coli predominates.\nVi khuẩn E. coli chiếm ưu thế.\n--------------------------------------------------\n149265\nKeywords: Brainstem glioma\nTừ khoá: U thần kinh đệm thân não\n--------------------------------------------------\n149532\nKeywords: TMA capsule.\nTừ khoá: Viên nang TMA.\n--------------------------------------------------\n149586\n21.8% was APR.\n21,8% PT Miles.\n--------------------------------------------------\n149587\n89.9% completed TME.\n89,9% thực hiện TME.\n--------------------------------------------------\n149985\nKeywords: Myocarditis-Dallas criteria\nTừ khoá: viêm cơ tim-tiêu chuẩn Dallas\n--------------------------------------------------\n150062\nBlood loss: 20mL.\nLượng máu mất 20 ml.\n--------------------------------------------------\n150125\nDesign: Longitudinal study.\nThiết kế: Nghiên cứu mô tả dọc.\n--------------------------------------------------\n150359\nKeywords: dementia, ADL\nTừ khoá: sa sút trí tuệ, ADL\n--------------------------------------------------\n151032\nTTP: Medican 3 months, mean: 3.6 months.\nSCTB: 8 tháng.\n--------------------------------------------------\n151396\nInflorescence is cymose.\nCụm hoa: kiểu xim.\n--------------------------------------------------\n151806\nMake EEG records.\nĐo điện não đồ ngoài cơn.\n--------------------------------------------------\n152212\nKeywords: colistin, nephrotoxicity\nTừ khoá: colistin, độc tính thận\n--------------------------------------------------\n152221\nBuried penis\nVùi dương vật\n--------------------------------------------------\n152224\nKeywords: Buried penis\nTừ khoá: vùi dương vật\n--------------------------------------------------\n152252\nKeywords: sepsis, bacteria.\nTừ khoá: Nhiễm trùng huyết, vi khuẩn.\n--------------------------------------------------\n152568\nFemales were 86.7%.\nNữ chiếm 86,7%.\n--------------------------------------------------\n152635\nMean age: 55.2.\nTuổi trung bình: 55,2.\n--------------------------------------------------\n153089\nDeath: 1case (2,22%).\nTử vong: 1 trường hợp (2,22%).\n--------------------------------------------------\n153156\n4.4% post-operative bleeding\nChảy máu sau mổ 4,4\n--------------------------------------------------\n154091\nOr Lymphoma?\nHay lymphoma?\n--------------------------------------------------\n154329\nFree margin 97%\nDiện cắt (-) 97%\n--------------------------------------------------\n154332\nOncologic results\nKết quả ung bướu\n--------------------------------------------------\n154333\nRecurrent rate\nTái phát\n--------------------------------------------------\n154334\nComplication rate93% 5,2%94%92,5%4,1%\nBiến chứng đạt 93%5,2% đạt 94% đạt 92,5%4,1%\n--------------------------------------------------\n154375\nFemale 61.3%.\nNữ 61,3%.\n--------------------------------------------------\n154488\nKeywords: Gastric trichobezoars.\nTừ khoá: Trichobezoars, dạ dày.\n--------------------------------------------------\n154901\nPudendal nerve block\nTê thần kinh thẹn\n--------------------------------------------------\n155135\nKeywords: tonsilitis, antibiogram\nTừ khoá: viêm amidan mạn, kháng sinh đồ\n--------------------------------------------------\n155201\n(p < 0.001).\n(p < 0,001).\n--------------------------------------------------\n155520\n(29.4%), Klebsiella spp.\n(29,4%), Klebsiella spp.\n--------------------------------------------------\n156256\n(25.37%), Acinetobacter spp.\n(25,37%), Acinetobacter spp.\n--------------------------------------------------\n157742\nJawndice (6.94%).\nSốt (6,94%).\n--------------------------------------------------\n157744\nTachypnea (59.72%).\nNhịp thở nhanh (59,72%).\n--------------------------------------------------\n157745\nBradycardia (1.39%).\nTần số tim chậm (1,39%).\n--------------------------------------------------\n157746\nPoor feeding (11.11%).\nBỏ bú (11,11%).\n--------------------------------------------------\n157747\nHypertonia (9.72%).\nTrương lực cơ tăng (9,72%).\n--------------------------------------------------\n158514\nKey words: Pharyngitis\nTừ khoá: viêm họng\n--------------------------------------------------\n158944\nKey words: Method-Document-Analysis\nTừ khoá: tài liệu-phân tích-phương pháp\n--------------------------------------------------\n159006\nMale/female ratio: 2.6.\nTỷ lệ nam/nữ = 2,6.\n--------------------------------------------------\n159993\nKey words: Lipid-prehypertension\nTừ khoá: Lipid-Tiền tăng huyết áp\n--------------------------------------------------\n160116\nMale/Female was 2.33.\nTỷ lệ nam/nữ: 2,33.\n--------------------------------------------------\n160799\nKey words: Tracheotomy\nTừ khoá: Mở khí quản\n--------------------------------------------------\n160871\nKey words: anapbylaxis\nTừ khoá: phản vệ\n--------------------------------------------------\n160881\nBackground: 1.\nĐặt vấn đề: 1.\n--------------------------------------------------\n160895\nResults 1.\nKết quả: 1.\n--------------------------------------------------\n161164\nBleeding intraoperative 10.3%.\nChảy máu trong mổ 10,3%.\n--------------------------------------------------\n161209\nResults: Acinetobacter sp.\nKết quả: Các loài Acinetobacter sp.\n--------------------------------------------------\n161771\nSpecificity is 42.75%.\nĐộ đặc hiệu: 42,75%.\n--------------------------------------------------\n161773\nSensitivity is 83.78%.\nĐộ nhạy: 83,78%.\n--------------------------------------------------\n161774\nSpecificity is 78.26%.\nĐộ đặc hiệu: 78,26%.\n--------------------------------------------------\n161778\nOligohydramnios is 30.3%.\nTỷ lệ thiểu ối 30,3%.\n--------------------------------------------------\n161781\nSensitivity is 97.67%.\nĐộ nhạy: 97,67%.\n--------------------------------------------------\n162613\nHuman infections with Lophomonas sp.\nNhiễm Lophomonas sp.\n--------------------------------------------------\n163094\n2male/female was 3.57/1.\nTỷ lệ nữ/nam là 3,57/1.\n--------------------------------------------------\n163844\nFemale/male 1.13.\nTỷ lệ nữ/nam: 1,13.\n--------------------------------------------------\n163845\nStone-free rate: 49.4%.\nTỷ lệ sạch sỏi là 49,4%.\n--------------------------------------------------\n164203\n96.7% were males\nNam chiếm 96,7\n--------------------------------------------------\n164779\nMethod: Retrospective cohort.\nThiết kế nghiên cứu: Hồi cứu thuần tập.\n--------------------------------------------------\n164998\n68,5% coutryside\nNông thôn 68,5\n--------------------------------------------------\n165288\nKey words: Epistaxis\nTừ khoá: Chảy máu mũi\n--------------------------------------------------\n165637\nRural areas: 85.4%.\nNông thôn: 85,4%.\n--------------------------------------------------\n165940\nFemale/man: 3/38.\nTỷ lệ nữ/nam: 3/38.\n--------------------------------------------------\n167419\nUpdate on chromoendoscopy.\nCập nhật về nội soi nhuộm màu.\n--------------------------------------------------\n167426\nKey words: Chromoendoscopy\nTừ khoá: Nội soi nhuộm màu\n--------------------------------------------------\n167671\nRobotic Surgery Overview.\nTổng quan về mổ với Robot.\n--------------------------------------------------\n168141\nEarly complication kate was 28.9%.\nBiến chứng 28,9%.\n--------------------------------------------------\n168305\nImmune changes 1.2.1.\nCác thay đổi miễn dịch 1.2.1.\n--------------------------------------------------\n168472\nPurpose 12.3.1.1.\nMục tiêu 12.3.1.1.\n--------------------------------------------------\n168485\nPurpose 22.3.2.1.\nMục tiêu 22.3.2.1.\n--------------------------------------------------\n168507\nTable 3.12.\nBảng 3.12.\n--------------------------------------------------\n168511\nTable 3.24.\nBảng 3.24.\n--------------------------------------------------\n168517\nTable 3.27.\nBảng 3.27.\n--------------------------------------------------\n168624\nSee the specialists.\nKhám các chuyên khoa.\n--------------------------------------------------\n168662\nTable 3.20.\nBảng 3.20.\n--------------------------------------------------\n168799\nGeneral features 3.1.1.\nĐặc điểm chung 3.1.1.\n--------------------------------------------------\n168913\nTracheal stenosis 1.1.1.\nBệnh lý hẹp khí quản 1.1.1.\n--------------------------------------------------\n168983\nCauses arterial hypotension.\nGây tụt huyết áp động mạch.\n--------------------------------------------------\n168988\nResearch subjects: 2.1.1.\nĐối tượng nghiên cứu: 2.1.1.\n--------------------------------------------------\n169007\nResearch criteria 2.5.1.\nCác tiêu chí nghiên cứu 2.5.1.\n--------------------------------------------------\n169020\nGender Table 3.2.\nGiới Bảng 3.2.\n--------------------------------------------------\n169155\nIntroduction: 2 pages.\nĐặt vấn đề 2 trang.\n--------------------------------------------------\n169168\nConclusion: 2 pages.\nKết luận: 2 trang.\n--------------------------------------------------\n169206\n-Stone number.\n-Số lượng sỏi.\n--------------------------------------------------\n169207\n-10-Biliary strictures.\n-Hẹp đường mật.\n--------------------------------------------------\n169325\nSUBJECTS 2.1.\nĐỐI TƯỢNG NGHIÊN CỨU 2.1.\n--------------------------------------------------\n169337\nCholangioscopy through CCC.\nNội soi đường mật qua ống nối mật-da.\n--------------------------------------------------\n169362\nIn the world 2.3.2.2.\nThế giới 2.3.2.2.\n--------------------------------------------------\n169394\nMethods a.\nPhương pháp nghiên cứu a.\n--------------------------------------------------\n169407\nCLINICAL RESEARCH 2.2.1.\nỨNG DỤNG LÂM SÀNG VẠT DA-CÂN DELTA 2.2.1.\n--------------------------------------------------\n169462\nClinical outcomes 3.2.1.\nKết quả ứng dụng lâm sàng 3.2.1.\n--------------------------------------------------\n169479\n(1 cases).\n(1 BN).\n--------------------------------------------------\n169602\nSkin grafts method 1.2.2.\nGhép da 1.2.2.\n--------------------------------------------------\n169819\nSupportive treatment 1.4.6.1.\nĐiều trị bổ trợ 1.4.6.1.\n--------------------------------------------------\n169820\nRadiotherapy 1.4.6.2.\nTia xạ 1.4.6.2.\n--------------------------------------------------\n169821\nChemotherapy 1.4.6.3.\nHoá chất 1.4.6.3.\n--------------------------------------------------\n169832\nMortality 2.3%6.3%0081.5.2.\nTử vong 2,3%6,3%001.5.2.\n--------------------------------------------------\n169835\nPostoperative complications: 10-20%.\nBiến chứng sau mổ 10-20%.\n--------------------------------------------------\n169841\nRESEARCH SUBJECT 2.2.1.\nĐỐ I TƯỢ NG NGHIÊN C ỨU 2.2.1.\n--------------------------------------------------\n169854\nResearch chart 2.3.3.\nSơ đồ nghiên cứu 2.3.3.\n--------------------------------------------------\n169861\nEvaluation standards 2.3.5.1.\nCác tiêu chuần đánh giá 2.3.5.1.\n--------------------------------------------------\n169866\nResearch criteria 2.3.6.1.\nCác chỉ tiêu nghiên cứu 2.3.6.1.\n--------------------------------------------------\n169875\n100% male.\n100% là nam giới.\n--------------------------------------------------\n169936\nSubclinical 4.2.2.1.\nCận lâm sàng 4.2.2.1.\n--------------------------------------------------\n169962\nIntraoperative outcomes 4.3.2.1.\nKết quả trong mổ 4.3.2.1.\n--------------------------------------------------\n169980\nEarly outcomes 4.3.3.1.\nKết quả sớm 4.3.3.1.\n--------------------------------------------------\n170039\nShape 1.1.2.\nHình thể 1.1.2.\n--------------------------------------------------\n170041\nRelations 1.1.4.\nLiên quan 1.1.4.\n--------------------------------------------------\n170047\nDIAGNOSIS 41.2.1.\nCHẨN ĐO ÁN 1.2.1.\n--------------------------------------------------\n170061\nHistopathology 1.3.1.1.\nGiải phẫu bệnh 1.3.1.1.\n--------------------------------------------------\n170066\nTREATMENT 1.4.1.\nĐIỀU TRỊ 1.4.1.\n--------------------------------------------------\n170105\nTable 3.4.\nBảng 3.4.\n--------------------------------------------------\n170179\nPulpal disease 1.2.1.\nBệnh tuỷ răng: 1.2.1.\n--------------------------------------------------\n170192\nDental radiography 1.3.1.\nPhim Xquang răng 1.3.1.\n--------------------------------------------------\n170220\nChapter 4DISCUSSION 4.1.\nChương 4BÀN LUẬN 4.1.\n--------------------------------------------------\n170331\nInclusion criteria 2.1.2.1.\nTiêu chuẩn chọn bệnh nhân 2.1.2.1.\n--------------------------------------------------\n170333\nStudy materials 2.2.1.\nVật liệu nghiên cứu 2.2.1.\n--------------------------------------------------\n170387\nTable 3.25.\nBảng 3.25.\n--------------------------------------------------\n170427\nSoardi G A.\nSoardi G. A.\n--------------------------------------------------\n170528\n-Flotrac/Vigileo System USA).\n-Hệ thống theo dõi huyết động Flotrac/Vigileo (Mỹ).\n--------------------------------------------------\n170583\nFigure 2.1.\nSơ đồ 2.1.\n--------------------------------------------------\n170596\nTable 3.16.\nBảng 3.16.\n--------------------------------------------------\n170680\n-Distribution shock.\n-Sốc rối loạn phân bố.\n--------------------------------------------------\n170712\n-Myocardial infarction.\n-Nhồi máu cơ tim cấp.\n--------------------------------------------------\n170721\nCHAPTER 3.\nCHƯƠNG 3.\n--------------------------------------------------\n170775\nTable 3.32.\nBảng 3.32.\n--------------------------------------------------\n170829\nX-ray image 2.2.1.\nHình ảnh x-quang 2.2.1.\n--------------------------------------------------\n170885\nPre-surgerical preparation.\nChuẩn bị trước mổ.\n--------------------------------------------------\n170897\nData processing methods.\nPhương pháp xử lý số liệu.\n--------------------------------------------------\n170904\nEvery 15-20 minutes.\nMỗi lần 15-20 phút.\n--------------------------------------------------\n170964\nSurgical results 4.2.1.\nĐánh giá kết quả phẫu thuật 4.2.1.\n--------------------------------------------------\n171053\n+ Measure indicators.\n+ Đo các chỉ số.\n--------------------------------------------------\n171112\nFigure 3.8.\nBiểu đồ 3.8.\n--------------------------------------------------\n171315\nRestore normal function.\nHồi phục chức năng bình thường.\n--------------------------------------------------\n171320\nMale accounts for 78.2%3.2.\nNam chiếm 78,2%3.2.\n--------------------------------------------------\n171323\nClinical features 3.2.1.1.\nLâm sàng 3.2.1.1.\n--------------------------------------------------\n171373\nClinic 4.2.1.1.\nLâm sàng 4.2.1.1.\n--------------------------------------------------\n171460\n158 references.\n158 tài liệu tham khảo.\n--------------------------------------------------\n171474\nLiver surgery 1.1.1.\nGiải phẫu gan 1.1.1.\n--------------------------------------------------\n171478\nSubclinic 1.2.2.1.\nCận lâm sàng 1.2.2.1.\n--------------------------------------------------\n171920\nCholangioscopic system CHF.\nMáy NSĐM CHF.\n--------------------------------------------------\n171937\nAccessment standards 2.3.1.\nChỉ tiêu nghiên cứu 2.3.1.\n--------------------------------------------------\n171940\nHematology and biochemistry.\nHuyết học và sinh hoá.\n--------------------------------------------------\n171946\nAge and gender.\nTuổi và giới.\n--------------------------------------------------\n171973\nTable 3.22.\nBảng 3.22.\n--------------------------------------------------\n172138\nEvaluation tools: 2.2.3.1.\nPhương tiện: 2.2.3.1.\n--------------------------------------------------\n172197\nCobra: 1.1.1.\nRắn hổ mang: 1.1.1.\n--------------------------------------------------\n172230\nNaja genus: a.\nCác loài rắn hổ mang: a.\n--------------------------------------------------\n172303\nResearch parameters: 2.2.2.1.\nCác chỉ tiêu nghiên cứu: 2.2.2.1.\n--------------------------------------------------\n172305\nSigns, symptoms.\nTriệu chứng.\n--------------------------------------------------\n172336\nFigure 3.4.\nBiểu đồ 3.4.\n--------------------------------------------------\n172364\nCHAPTER 4.\nCHƯƠNG 4.\n--------------------------------------------------\n172397\nCHAPTER 1.\nCHƯƠNG 1.\n--------------------------------------------------\n172411\nHypertriglyceridemic pancreatitis 1.1.1.\nViêm tuỵ cấp do tăng TG 1.1.1.\n--------------------------------------------------\n172459\nSelection Criteria a.\nTiêu chuẩn chọn BN vào nghiên cứu a.\n--------------------------------------------------\n172530\nExclusion criteria.\nTiêu chuẩn loại trừ.\n--------------------------------------------------\n172541\nTechnical protocol 2.2.3.1.\nCác qui trình kỹ thuật 2.2.3.1.\n--------------------------------------------------\n172542\nComputed tomography-Topogram acquisition.\nChụp cắt lớp vi tính-Chụp cắt lớp Topogram.\n--------------------------------------------------\n172550\n-Group 6-infrapyloric LNs.\n-Nhóm 6-hạch dưới môn vị.\n--------------------------------------------------\n172566\nStudy parameters 2.2.4.1.\nCác nội dung nghiên cứu 2.2.4.1.\n--------------------------------------------------\n172567\n-Gender.\n-Giới.\n--------------------------------------------------\n172573\n-Venous invasion.\n-Xâm lấn tĩnh mạch.\n--------------------------------------------------\n172585\nStatistical analysis 2.2.5.1.\nXử lý số liệu 2.2.5.1.\n--------------------------------------------------\n172694\n-5-Duodenal cancer.\n-Ung thư tá tràng.\n--------------------------------------------------\n172997\nResearch methodology 2.2.1.\nP ơn p áp n iên cứu 2.2.1.\n--------------------------------------------------\n173181\nSampling method 2.2.2.1.\nPhương pháp chọn mẫu 2.2.2.1.\n--------------------------------------------------\n173186\nResearch materials 2.2.4.\nPhương tiện nghiên cứu 2.2.4.\n--------------------------------------------------\n173323\nMonopolar-resector Figure 1.6.\nMáy cắt đơn cực (monopolar-resector) Hình 1.6.\n--------------------------------------------------\n173339\nInfectious complications 1.2.6.4.\nBiến chứng nhiễm khuẩn 1.2.6.4.\n--------------------------------------------------\n173686\n-Coronary angiography.\n-Chụp động mạch vành.\n--------------------------------------------------\n173722\nPurpose-Improve flapping skills.\nMục đích-Nâng cao kỹ năng bóc vạt.\n--------------------------------------------------\n173737\n-Surgical plan development.\n-Xây dựng kế hoạch phẫu thuật.\n--------------------------------------------------\n173762\nRESULTS 2.3.1.\nKẾT QUẢ NGHIÊN CỨU 2.3.1.\n--------------------------------------------------\n173767\nRESEARCH ETHICS.\nĐẠO ĐỨC NGHIÊN CỨU.\n--------------------------------------------------\n173782\nSURGICAL RESULTS 3.3.1.\nKẾT QUẢ PHẪU THUẬT 3.3.1.\n--------------------------------------------------\n173842\nChemotherapy 1.1.3.2.\nHoá trị liệu 1.1.3.2.\n--------------------------------------------------\n173874\nOral cancer patients.\nCác bệnh nhân ung thư khoang miệng.\n--------------------------------------------------\n173918\nFigure 3.10.\nBiểu đồ 3.10.\n--------------------------------------------------\n174074\nCHAPTER 2.\nCHƯƠNG 2.\n--------------------------------------------------\n174082\n-No branch block.\n-Không có block nhánh.\n--------------------------------------------------\n174102\n-Gender: men, women.\n-Giới: nam, nữ.\n--------------------------------------------------\n174127\nCHAPTER III.\nCHƯƠNG III.\n--------------------------------------------------\n174441\nProcessing 2.1.4.1.\nTiến hành nghiên cứu 2.1.4.1.\n--------------------------------------------------\n174449\nBile duct dilatation.\nGiãn đường mật kèm theo.\n--------------------------------------------------\n174454\nStudy devices 2.2.3.\nPhương tiện nghiên cứu 2.2.3.\n--------------------------------------------------\n174455\nResearch criteria 2.4.1.\nCác chỉ tiêu nghiên cứu 2.4.1.\n--------------------------------------------------\n174559\nOther complications 1.1.3.\nMột số biến chứng khác 1.1.3.\n--------------------------------------------------\n174563\nSurgical treatment 1.1.3.4.\nĐiều trị ngoại khoa 1.1.3.4.\n--------------------------------------------------\n174568\nEndoscopic screening 1.2.3.\nNội soi thực quản-dạ dày-tá tràng 1.2.3.\n--------------------------------------------------\n174569\nInvasive treatment 1.2.4.\nCác phương pháp chẩn đoán xâm nhập 1.2.4.\n--------------------------------------------------\n174888\n(p > 0.05).\n(p > 0,05).\n--------------------------------------------------\n175425\nModerate: shallow ulceration.\nVừa: Chợt loét nông.\n--------------------------------------------------\n175451\nDamage characteristics 3.2.2.1.\nĐặc điểm tổn thương 3.2.2.1.\n--------------------------------------------------\n175524\nGeneral features 4.2.2.\nĐặc điểm chung 4.2.2.\n--------------------------------------------------\n175525\nDamage characteristics 4.2.3.\nĐặc điểm tổn thương 4.2.3.\n--------------------------------------------------\n175613\nPerforator flap 1.1.3.1.\nVạt mạch xuyên 1.1.3.1.\n--------------------------------------------------\n175809\nLanger J S.\nNghiên cứu của Langer J. S.\n--------------------------------------------------\n175868\nMETHODOLOGY 2.2.1.\nPHƠNG PHÁP NGHIÊN CỨU 2.2.1.\n--------------------------------------------------\n175869\nMeterials 2.2.3.\nPhơng tiện, dụng cụ 2.2.3.\n--------------------------------------------------\n175870\nPost-operative management 2.2.5.\nSăn sóc, điều trị sau mổ 2.2.5.\n--------------------------------------------------\n175880\nStudy design 2.3.\nSơ đồ nghiên cứu 2.3.\n--------------------------------------------------\n175943\n(Chart 3.13).\n(Biểu đồ 3.13).\n--------------------------------------------------\n176028\nDrugs and facilities.\nThuốc và phương tiện nghiên cứu.\n--------------------------------------------------\n176045\nMethod to proceed.\nPhương pháp tiến hành.\n--------------------------------------------------\n176279\nBoard 3.21.\nBảng 3.21.\n--------------------------------------------------\n176349\nResearch criteria 2.2.4.1.\nCác chỉ tiêu nghiên cứu 2.2.4.1.\n--------------------------------------------------\n176449\nIntraoperative Table 3.\nTrong mổ Bảng 3.\n--------------------------------------------------\n176591\nOVERVIEW 1.1.\nCHƯƠNG I: TỔNG QUAN 1.1.\n--------------------------------------------------\n176604\nSubclinical 1.3.2.1.\nCận lâm sàng 1.3.2.1.\n--------------------------------------------------\n176623\n-Edi trigger: 0.5µV.\n-Edi trigger: 0,5 µV.\n--------------------------------------------------\n176771\nPhysiological basis 1.2.2.\nCơ sở sinh lý học 1.2.2.\n--------------------------------------------------\n176835\nDr H U.\nTác giả H. U.\n--------------------------------------------------\n176944\nScreen 2.4.\nHình 2.4.\n--------------------------------------------------\n176999\nVomiting and nausea.\nNôn và buồn nôn.\n--------------------------------------------------\n177150\n-Patient awake.\n-Bệnh nhân tỉnh.\n--------------------------------------------------\n177314\nEvaluation criteria 2.2.4.1.\nCác tiêu chí đánh giá 2.2.4.1.\n--------------------------------------------------\n177618\nHEMOCLIP METHOD 1.5.1.\nPHƯƠNG PHÁP KẸP CLIP CẦM MÁU 1.2.1.\n--------------------------------------------------\n177665\nIdentify results 2.2.4.1.\nNhận định kết quả 2.2.4.1.\n--------------------------------------------------\n177732\nTable 3.37.\nBảng 3.37.\n--------------------------------------------------\n177736\nTable 3.41.\nBảng 3.41.\n--------------------------------------------------\n177738\nFigure 3.16.\nBiểu đồ 3.16.\n--------------------------------------------------\n177769\nTable 4.2.\nBảng 4.2.\n--------------------------------------------------\n177844\nStructure 1.2.2.3.\nCấu trúc 1.2.2.3.\n--------------------------------------------------\n177852\nFig.1.12.\nHình 1.12.\n--------------------------------------------------\n177871\nControl group 2.1.2.1.\nNhóm chứng 2.1.2.1.\n--------------------------------------------------\n177897\n-The emergence of anesthesia: 2.3.\n-Thoát mê: 2.3.\n--------------------------------------------------\n178012\nLow-flow anesthesia 1.2.1.\nGây mê dòng thấp 1.2.1.\n--------------------------------------------------\n178091\nTable 0.29.\nBảng 0.29.\n--------------------------------------------------\n178094\nTable 0.31.\nBảng 0.31.\n--------------------------------------------------\n178096\nGraph 0.1.\nBiểu đồ 0.1.\n--------------------------------------------------\n178171\nSeptic shock 1.2.1.\nSốc nhiễm khuẩn 1.2.1.\n--------------------------------------------------\n178187\nFig.9.\nHình 1.9.\n--------------------------------------------------\n178202\nResearch progress 2.2.6.1.\nCác bớc tiến hành nghiên cứu 2.2.6.1.\n--------------------------------------------------\n178268\nFigure 3.11.\nBiểu đồ 3.11.\n--------------------------------------------------\n178305\nPERIODONTAL DISEASE 1.1.1.\nBỆNH NHA CHU 1.1.1.\n--------------------------------------------------\n178356\nDIABETIC DISEASE 1.2.1.\nBỆNH ÁI THÁO ỜNG 1.2.1.\n--------------------------------------------------\n178376\nExamination material-Research form.\nPhương tiện khám RHM-Phiếu nghiên cứu.\n--------------------------------------------------\n178435\nChart 3.21.\nBiểu đồ 3.21.\n--------------------------------------------------\n178438\nChart 3.24.\nBiểu đồ 3.24.\n--------------------------------------------------\n178611\nTable 1.2.\nBảng 1.\n--------------------------------------------------\n178615\n+ Limb salvage.\n+ Bảo tồn tối đa chi thể.\n--------------------------------------------------\n178637\n-ABI index\n-Chẩn đoán hình ảnh\n--------------------------------------------------\n178792\n2 Fgure 1.2.\nHình 1.2.\n--------------------------------------------------\n178819\n-CT Toshiba (Japan).\n-Máy CT Toshiba (Nhật Bản).\n--------------------------------------------------\n178893\nFollow up 2.4.\nTheo dõi bệnh nhân sau phẫu thuật 2.4.\n--------------------------------------------------\n179059\nECG Holter 1.2.1.\nHolter điện tim 1.2.1.\n--------------------------------------------------\n179393\nCardiac dysfunction.\nRối loạn chức năng tim.\n--------------------------------------------------\n179400\n* Vasopressor drugs.\n* Thuốc vận mạch.\n--------------------------------------------------\n179415\n-Determining the burden.\n-Xác định tiền gánh.\n--------------------------------------------------\n179416\n-Evaluation response compensation.\n-Đánh giá đáp ứng bù dịch.\n--------------------------------------------------\n179417\n-Assess cardiac contractility.\n-Đánh giá sức co bóp của cơ tim.\n--------------------------------------------------\n179421\nZ: confidence coefficient.\nZ: hệ số tin cậy.\n--------------------------------------------------\n179424\nStudy equipment 2.3.1.\nPhương tiện nghiên cứu 2.3.1.\n--------------------------------------------------\n179427\nStudy implementation 2.4.4.1.\nTiến hành nghiên cứu 2.4.4.1.\n--------------------------------------------------\n179443\nProtocols 2.3.3.1.\nCác bước tiến hành 2.3.3.1.\n--------------------------------------------------\n179517\n86,9% were male\nNam giới chiếm 86,9\n--------------------------------------------------\n179556\n+ Other symptoms.\n+ Tổn thương khác.\n--------------------------------------------------\n179730\nNeedle size 20-22G.\nKim tiêm 20-22 G.\n--------------------------------------------------\n179748\nTable 3.15.\nBảng 3.15.\n--------------------------------------------------\n179852\nneurohormonal activation; 5).\nHoạt động thần kinh thể dịch; 5).\n--------------------------------------------------\n179853\nInflammation; and 6).\nĐáp ứng viêm; 6).\n--------------------------------------------------\n179854\noxidative stress.\nStress oxy hoá.\n--------------------------------------------------\n179904\nWednesday\nThứ tư\n--------------------------------------------------\n180073\nCOMMENTARY\nBÀN LUẬN\n--------------------------------------------------\n180265\nStay well hydrated.\nGiữ đủ nước.\n--------------------------------------------------\n180328\nKeywords: Diabetes management.\nTừ khoá: Quản lý bệnh đái tháo đường.\n--------------------------------------------------\n181123\nCIGARETTE SMOKING\nThuốc lá\n--------------------------------------------------\n181265\nType 1 diabetes\nBệnh đái tháo đường típ 1\n--------------------------------------------------\n181270\nType 2 diabetes\nBệnh đái tháo đường típ 2\n--------------------------------------------------\n181280\nPostdiagnostic testing\nKiểm tra hậu chẩn đoán\n--------------------------------------------------\n181282\nSerum creatinine\nHuyết thanh creatinine\n--------------------------------------------------\n181283\nFree thyroxine levels\nMức thyroxine tự do\n--------------------------------------------------\n181291\nElectrocardiography\nĐiện tim\n--------------------------------------------------\n181304\nGestational Diabetes\nĐái tháo đường thai kỳ\n--------------------------------------------------\n181374\nYes.\nCó.\n--------------------------------------------------\n181441\nOf course.\nTất nhiên.\n--------------------------------------------------\n181450\nVentilated patients: 60.7%.\nTỉ lệ thở máy: 60,7%.\n--------------------------------------------------\n181451\nMortality rate: 67.1%.\nTỉ lệ tử vong: 67,1%.\n--------------------------------------------------\n181472\nGender: female/male: 62.7%/37.3%.\nGiới tính: nữ/nam: 62,7%/37,3%.\n--------------------------------------------------\n181515\n(See 'Pathogenesis' above.)\n(Xem ' Sinh bệnh học ' ở trên.)\n--------------------------------------------------\n181520\n(See 'Diagnosis' above.)\n(Xem phần ' Chẩn đoán ' ở trên.)\n--------------------------------------------------\n181527\n(See 'Treatment' above.)\n(Xem phần ' Điều trị ' ở trên.)\n--------------------------------------------------\n181644\n\"This warrants clarification\n\"Điều này cần được làm rõ\n--------------------------------------------------\n181769\na. Screening\na. Sàng lọc\n--------------------------------------------------\n181772\nb. Diagnosis\nb. Chẩn đoán\n--------------------------------------------------\n181775\nc. Evaluation\nc. Đánh giá\n--------------------------------------------------\n181779\nd. Treatment\nd. Điều trị\n--------------------------------------------------\n182014\nGOAL BLOOD PRESSURE\nMỤC TIÊU HUYẾT ÁP\n--------------------------------------------------\n182029\nIncreased exercise\nTăng cường tập thể dục\n--------------------------------------------------\n182039\n-Chronic kidney disease\n-Bệnh thận mạn\n--------------------------------------------------\n182247\nHeald wondered.\nHeald thắc mắc.\n--------------------------------------------------\n182675\nHypothalamic-pituitary-thyroid axis\nTrục hạ đồi-tuyến yên-tuyến giáp\n--------------------------------------------------\n182684\nDiabetes insipidus\nĐái tháo nhạt\n--------------------------------------------------\n182777\nClinical approach\nTiếp cận lâm sàng\n--------------------------------------------------\n182823\nSheehan syndrome\nHội chứng Sheehan\n--------------------------------------------------\n182893\nDifferential Diagnosis\nChẩn đoán phân biệt\n--------------------------------------------------\n183931\nBackground and aims\nBối cảnh và mục tiêu\n--------------------------------------------------\n184034\n(See \"Exogenous hyperthyroidism\n(Xem \"Cường giáp ngoại sinh\n--------------------------------------------------\n184036\n(See \"Struma ovarii\n(Xem \"U quái giáp\n--------------------------------------------------\n184045\n(See 'Introduction' above.)\n(Xem ' Giới thiệu ' ở trên.)\n--------------------------------------------------\n184294\nHyperthyroidism in Pregnancy.\nCường giáp trong thai kỳ ngannguyen 28/06/2021.\n--------------------------------------------------\n184634\nHow well?\nTốt như thế nào?\n--------------------------------------------------\n184869\nFollicle-stimulating hormone\nHormone kích thích nang trứng\n--------------------------------------------------\n185170\nKeyword: Eating tradition.\nTừ khoá: Truyền thống ăn uống.\n--------------------------------------------------\n185255\nFile attachments:\nSummary Tài liệu đính kèm:\n--------------------------------------------------\n185303\nKeyword: File attachments:\nTừ khoá: Tài liệu đính kèm:\n--------------------------------------------------\n185589\nKeyword: Hypertension, adults.\nTừ khoá: Tăng huyết áp, người trưởng thành.\n--------------------------------------------------\n185904\nImproving feeding practices.\nCải thiện thực hành nuôi dưỡng.\n--------------------------------------------------\n186813\nAuthor: Prof dr.\nTác giả: Prof. dr.\n--------------------------------------------------\n186855\nRussulla foetens (Per.)\nNấm xốp thối [Russula foetens (Per.)\n--------------------------------------------------\n187311\nEnglish summary: 1.\nTóm tắt tiếng Việt: 1.\n--------------------------------------------------\n188549\nKeyword: Obesity, Overweight.\nTừ khoá: Thừa cân, Béo phì.\n--------------------------------------------------\n190950\nDiagnosis is clinical.\nChẩn đoán là lâm sàng.\n--------------------------------------------------\n191374\nOpioids should be avoided.\nNên tránh opioid.\n--------------------------------------------------\n191580\nBiopsy is done.\nSinh thiết được thực hiện.\n--------------------------------------------------\n191598\nRecurrence is common.\nSự tái phát là phổ biến.\n--------------------------------------------------\n191868\nIt weakens bone.\nNó làm suy yếu xương.\n--------------------------------------------------\n192148\nPalpate the landmarks.\nSờ các điểm mốc đánh dấu.\n--------------------------------------------------\n192513\nC-reactive protein is also elevated.\nCRP cũng tăng.\n--------------------------------------------------\n192590\nPathogenesis is unknown.\nSinh bệnh học không rõ.\n--------------------------------------------------\n192748\nEtiology is unknown.\nNguyên nhân chưa được hiểu rõ.\n--------------------------------------------------\n192839\nDiagnosis requires biopsy.\nChẩn đoán đòi hỏi phải sinh thiết.\n--------------------------------------------------\n192874\nArthritis may occur.\nCó thể viêm khớp.\n--------------------------------------------------\n193805\n(See also Bursitis.)\n(Xem thêm Viêm bao thanh dịch.)\n--------------------------------------------------\n193848\nBursal fluid reaccumulates.\nDịch bao hoạt dịch tích tụ lại.\n--------------------------------------------------\n194106\nMechanism is unknown.\nCơ chế này vẫn chưa được biết.\n--------------------------------------------------\n195125\nOliguria is typical.\nTiểu ít thì điển hình.\n--------------------------------------------------\n195759\nPellagra develops rarely.\nBệnh Pellagra hiếm khi phát triển.\n--------------------------------------------------\n196456\nAdapted from Fagan TJ.\nTheo Fagan TJ.\n--------------------------------------------------\n197806\nHappy Studying!\nHọc tập vui vẻ!\n--------------------------------------------------\n197819\nCusters, E J.\nCusters, E. J.\n--------------------------------------------------\n197831\nRoediger, H L.\nRoediger, H. L.\n--------------------------------------------------\n198149\nInjuries are common.\nThương tích thường gặp.\n--------------------------------------------------\n198986\nAppetite often increases.\nTăng Sự thèm ăn.\n--------------------------------------------------\n199162\nDelirium is common.\nMê sảng thường phổ biến.\n--------------------------------------------------\n199983\nTumors require adrenalectomy.\nKhối u cần phẫu thuật.\n--------------------------------------------------\n200418\nPass it on.\nHãy cùng truyền bá.\n--------------------------------------------------\n201920\nLibido may decrease.\nLibido có thể giảm.\n--------------------------------------------------\n203317\nThe prognosis is poor.\nTiên lượng kém.\n--------------------------------------------------\n203325\nStaging is surgical.\nGiai đoạn dựa vào phẫu thuật.\n--------------------------------------------------\n207511\nDrowsiness may occur.\nCó thể gây buồn ngủ.\n--------------------------------------------------\n207721\nThe cyst is tender.\nNang căng tức.\n--------------------------------------------------\n207915\n(See also Hypertension.)\n(Xem thêm Thuốc hạ áp.)\n--------------------------------------------------\n208078\nPapilledema occasionally occurs.\nPhù đĩa thị thỉnh thoảng xảy ra.\n--------------------------------------------------\n208567\nTable Table\nBảng Bảng\n--------------------------------------------------\n209167\nTreatment is symptomatic.\nĐiều trị triệu chứng.\n--------------------------------------------------\n209283\nPelvic organ prolapse\nSa các cơ quan vùng chậu\n--------------------------------------------------\n209291\nDyspareunia can occur.\nChứng giao hợp đau có thể xảy ra.\n--------------------------------------------------\n211066\nDepression occurs frequently.\nTrầm cảm xảy ra một cách thường xuyên.\n--------------------------------------------------\n212433\nComorbidities are complex.\nBệnh lý đồng diễn thường phức tạp.\n--------------------------------------------------\n212536\nComorbidities are common.\nBệnh lý đồng diễn là phổ biến.\n--------------------------------------------------\n213528\njaw thrust) is required\nĐẩy hàm\n--------------------------------------------------\n213915\nReapply the tourniquet.\nBăng lại garô.\n--------------------------------------------------\n213931\nRemove the needle.\nRút kim.\n--------------------------------------------------\n214461\nDeath can result.\nTử vong có thể xảy ra.\n--------------------------------------------------\n215363\nArrhythmias may occur.\nLoạn nhịp tim có thể xảy ra.\n--------------------------------------------------\n216098\nInflate the cuff.\nBơm phồng.\n--------------------------------------------------\n216154\nInflate the cuffs.\nThổi phồng còng.\n--------------------------------------------------\n216190\nEstablish IV access.\nThiết lập đường truyền tĩnh mạch.\n--------------------------------------------------\n216198\nContinue oxygenation.\nTiếp tục oxy.\n--------------------------------------------------\n216742\nOptimize imaging.\nTối ưu hoá hình ảnh.\n--------------------------------------------------\n216902\nLacerations hemorrhage immediately.\nSự giằng xé gây xuất huyết ngay.\n--------------------------------------------------\n217292\nAchieve hemostasis.\nĐã cầm máu.\n--------------------------------------------------\n217371\nTie the suture.\nThắt chỉ.\n--------------------------------------------------\n217599\nX-rays are diagnostic.\nX-quang dùng để chuẩn đoán.\n--------------------------------------------------\n217823\nDrape the area.\nTrải săng vùng đặt dẫn lưu.\n--------------------------------------------------\n217993\nBridging 1.\nBắc cầu 1.\n--------------------------------------------------\n218068\nLower and repeat.\nHạ xuống và lặp lại.\n--------------------------------------------------\n218115\nRotate forearm upward.\nXoay cẳng tay lên trên.\n--------------------------------------------------\n218184\nToe Walking 1.\nĐi bằng ngón chân 1.\n--------------------------------------------------\n218190\nHeel Walking 1.\nĐi bằng gót chân 1.\n--------------------------------------------------\n218194\nHeel Raises 1.\nNâng gót chân 1.\n--------------------------------------------------\n218288\nQuadriceps Set 1.\nBộ cơ tứ đầu đùi 1.\n--------------------------------------------------\n218300\nPerform abdominal contraction.\nThực hiện động tác co bụng.\n--------------------------------------------------\n219303\nGangrene may develop.\nHoại thư sinh hơi có thể hình thành.\n--------------------------------------------------\n219421\nNicotine should be avoided.\nNicotine nên tránh.\n--------------------------------------------------\n219427\nOccasionally, symptoms recur.\nThỉnh thoảng, các triệu chứng tái diễn.\n--------------------------------------------------\n219860\nEncephalopathy is unusual.\nBệnh não là không thường xảy ra.\n--------------------------------------------------\n222075\n(See also Burns.)\n(Xem thêm Bỏng.)\n--------------------------------------------------\n222354\nShock is common.\nThường hay sốc.\n--------------------------------------------------\n222814\nTreat patients supportively.\nĐiều trị hỗ trợ bệnh nhân.\n--------------------------------------------------\n223155\nRemove the cast.\nBỏ bột bó ra.\n--------------------------------------------------\n223228\nDeath is common.\nThường là tử vong.\n--------------------------------------------------\n223388\nWeekdays: (865) 576-3131.\nCác ngày trong tuần: (865) 576-3131.\n--------------------------------------------------\n223392\n(Ask for REAC/TS).\n(Yêu cầu REAC/TS).\n--------------------------------------------------\n224041\nAnalgesics are given.\nCho thuốc giảm đau.\n--------------------------------------------------\n224056\nEncourage early mobilization.\nKhuyến khích vận động sớm.\n--------------------------------------------------\n224143\nTreatment is fasciotomy.\nĐiều trị là mở cân giải phóng khoang.\n--------------------------------------------------\n224979\n(See also Hypercalcemia.)\n(Xem thêm Tăng canxi máu.)\n--------------------------------------------------\n225772\nArrange orthopedic follow-up.\nSắp xếp theo dõi chấn thương chỉnh hình.\n--------------------------------------------------\n226488\nEstablish intravenous access.\nThiết lập đường vào tĩnh mạch.\n--------------------------------------------------\n226895\nVision is decreased.\nBệnh nhân có biểu hiện giảm thị lực.\n--------------------------------------------------\n227046\nMild irritation occurs.\nKích thích nhẹ.\n--------------------------------------------------\n228167\nPhotosensitivity is possible.\nCó thể có nhạy cảm ánh sáng.\n--------------------------------------------------\n228458\nIntraocular pressure is measured.\nĐo nhãn áp.\n--------------------------------------------------\n229160\nPain is absent.\nKhông đau tại chỗ.\n--------------------------------------------------\n229516\nDo not patch the eye.\nKhông vá mắt.\n--------------------------------------------------\n229589\nMetastasis is rare.\nDi căn rất hiếm.\n--------------------------------------------------\n229689\nReflux indicates stenosis.\nPhụt ngược cho thấy tắc.\n--------------------------------------------------\n229847\nFever is usually present.\nThường có sốt.\n--------------------------------------------------\n230353\nIt impairs clotting.\nNó gây rối loạn đông máu.\n--------------------------------------------------\n230401\nMuscle wasting occurs.\nThấy cơ bắp yếu.\n--------------------------------------------------\n230496\nThe cortex thins.\nXương vỏ mỏng đi.\n--------------------------------------------------\n230866\nToxicity is rare.\nNhiễm độc là rất hiếm.\n--------------------------------------------------\n232641\nSBP is suspected.\nNghi ngờ SBP.\n--------------------------------------------------\n232696\n(See also Ascites.)\n(Xem thêm Cổ trướng.)\n--------------------------------------------------\n233040\nFever may occur.\nSốt có thể xuất hiện.\n--------------------------------------------------\n233980\nConsider liver biopsy.\nXem xét sinh thiết gan.\n--------------------------------------------------\n234306\nTreat supportively.\nĐiều trị hỗ trợ.\n--------------------------------------------------\n234494\nNo vaccine is available.\nKhông có vắc-xin.\n--------------------------------------------------\n234754\nThe liver enlarges.\nGan to.\n--------------------------------------------------\n234782\nPancreatitis is common.\nViêm tuỵ thường gặp.\n--------------------------------------------------\n234822\nPrognosis is variable.\nTiên lượng thay đổi tuỳ trường hợp.\n--------------------------------------------------\n234871\nSeizures may occur.\nĐộng kinh có thể xảy ra.\n--------------------------------------------------\n237601\nRehydration is important.\nBù nước là rất quan trọng.\n--------------------------------------------------\n238106\nDistribution reference 1.\nTham khảo về phân phối 1.\n--------------------------------------------------\n240022\nSore throat develops.\nĐau họng tiến triển.\n--------------------------------------------------\n240104\nAspirate while advancing.\nHút nước tiểu trong khi đẩy kim.\n--------------------------------------------------\n240148\nRemove the drapes.\nBỏ săng phẫu thuật ra.\n--------------------------------------------------\n240165\nOxygen reference 1.\nTài liệu tham khảo về oxy 1.\n--------------------------------------------------\n240175\nCPAP references 1.\nTài liệu tham khảo về CPAP 1.\n--------------------------------------------------\n240411\nDeath is rare.\nHiếm khi tử vong.\n--------------------------------------------------\n242699\nOrthotics may help.\nBác sỹ chỉnh hình có thể giúp đỡ.\n--------------------------------------------------\n244688\nMultiple protocols exist.\nCó nhiều phác đồ điều trị.\n--------------------------------------------------\n245135\nDR M A.\nBÁC SĨ M. A.\n--------------------------------------------------\n245438\nTetracycline is contraindicated.\nTetracyclinechống chỉ định.\n--------------------------------------------------\n246829\nMethylmalonic acid accumulates.\nTích tụ axit methylmalonic.\n--------------------------------------------------\n247192\nPrognosis is excellent.\nTiên lượng rất tốt.\n--------------------------------------------------\n249433\nSclerae are blue.\nCủng mạc mắt màu xanh.\n--------------------------------------------------\n249439\nScleral hue varies.\nMàu sắc củng mạc mắt thay đổi.\n--------------------------------------------------\n249641\n(See also ArginineVasopressinDeficiency.)\n(Xem thêm Thiếu hụt arginine vasopressin.)\n--------------------------------------------------\n249715\nSpironolactone is ineffective.\nSpironolactone không có hiệu quả.\n--------------------------------------------------\n250713\nMechanism is unclear.\nCơ chế chưa rõ ràng.\n--------------------------------------------------\n250759\nFewer develop sepsis.\nMột vài trường hợp có nhiễm trùng huyết.\n--------------------------------------------------\n250810\nHematuria is common.\nĐái máu là phổ biến.\n--------------------------------------------------\n250909\nInfections are complicated.\nNhiễm trùng có biến chứng.\n--------------------------------------------------\n250910\nNephrolithiasis is suspected.\nNghi ngờ sỏi thận.\n--------------------------------------------------\n251677\nInheritance is variable.\nSự di truyền khá đa dạng.\n--------------------------------------------------\n252335\nDon sterile gloves.\nĐi găng tay vô trùng.\n--------------------------------------------------\n252365\nOpen the stopcock.\nMở khoá vòi.\n--------------------------------------------------\n252538\nHypertension sometimes develops.\nTăng huyết áp đôi khi xuất hiện.\n--------------------------------------------------\n252893\nPain is uncommon.\nĐau không phổ biến.\n--------------------------------------------------\n252903\nTreatment includes excision.\nĐiều trị gồm phẫu thuật cắt bỏ.\n--------------------------------------------------\n253146\nCleanse the region.\nLàm sạch khu vực đó.\n--------------------------------------------------\n254095\nEndopelvic fascia weakens.\nCân cơ đáy chậu trở lên yếu.\n--------------------------------------------------\n255516\nFever is common.\nSốt là triệu chứng phổ biến.\n--------------------------------------------------\n255554\n(See also Poliomyelitis.)\n(Xem thêm Bệnh bại liệt.)\n--------------------------------------------------\n255722\nPharmacokinetics reference 1.\nTham khảo dược động học 1.\n--------------------------------------------------\n256043\nNephrotoxicity is rare.\nĐộc tính với thận là hiếm gặp.\n--------------------------------------------------\n256363\nContraindications references 1.\nTham khảo chống chỉ định 1.\n--------------------------------------------------\n257167\nHoarseness may occur.\nCó thể khàn tiếng.\n--------------------------------------------------\n257168\nFever is rare.\nSốt là rất hiếm.\n--------------------------------------------------\n257712\nTransmission reference 1.\nTruyền thông tin tham khảo 1.\n--------------------------------------------------\n258280\nLymphadenopathy is uncommon.\nNổi hạch là không phổ biến.\n--------------------------------------------------\n259121\nA vaccine is available.\nVắc-xin sẵn có.\n--------------------------------------------------\n260322\nPrevention involves vaccination.\nPhòng ngừa liên quan đến tiêm vắc xin.\n--------------------------------------------------\n260869\nAvoid stirring up dust.\nTránh quấy bụi.\n--------------------------------------------------\n260911\nNo vaccine for Lassa fever is available.\nKhông có vaccine.\n--------------------------------------------------\n263133\nTreat with praziquantel.\nĐiều trị bằng praziquantel.\n--------------------------------------------------\n263771\nEEG is done.\nCần thực hiện điện não đồ.\n--------------------------------------------------\n263974\nEosinophilia is common.\nTăng bạch cầu ái toan là phổ biến.\n--------------------------------------------------\n264239\nTheir appearance varies.\nHình thái của chúng khác nhau.\n--------------------------------------------------\n264746\nSymptoms are biphasic.\nTriệu chứng là hai pha.\n--------------------------------------------------\n265104\nCysticercosis can result.\nBệnh do cysticercus có thể dẫn đến.\n--------------------------------------------------\n266132\nSometimes bullae develop.\nĐôi khi có thể có phỏng nước.\n--------------------------------------------------\n267376\nEventually, exfoliation occurs.\nCuối cùng, loại bỏ lớp da chết.\n--------------------------------------------------\n267760\nSplenomegaly sometimes occurs.\nĐôi khi có lách to.\n--------------------------------------------------\n267787\nMortality is nil.\nBệnh không gây tử vong.\n--------------------------------------------------\n268126\n(See also Epistaxis.)\n(Xem thêm Chảy máu cam.)\n--------------------------------------------------\n268450\nShip, DMD.\nShip cung cấp.\n--------------------------------------------------\n268862\nFever is uncommon.\nSốt thường không phổ biến.\n--------------------------------------------------\n269321\nRetest hearing.\nKiểm tra lại thính lực.\n--------------------------------------------------\n269905\nOtalgia is rare.\nĐau tai hiếm.\n--------------------------------------------------\n269992\nDrainage is cultured.\nMủ tai được nuôi cấy.\n--------------------------------------------------\n270733\nReflexes are tested.\nKiểm tra phản xạ.\n--------------------------------------------------\n270913\nTrismus is minimal.\nCứng hàm không đáng kể.\n--------------------------------------------------\n272024\nFatigue is common.\nBệnh nhân thường mệt mỏi.\n--------------------------------------------------\n272518\nPosture becomes stooped.\nTư thế bệnh nhân trở nên cúi gù.\n--------------------------------------------------\n272665\nGait is observed.\nTiến hành quan sát dáng đi.\n--------------------------------------------------\n272777\nDosage varies greatly.\nLiều dùng rất khác nhau.\n--------------------------------------------------\n273168\nThe neck is often stiff.\nCổ thường cứng.\n--------------------------------------------------\n273345\nComplications are minimal.\nCác biến chứng là tối thiểu.\n--------------------------------------------------\n274179\nFour are available.\nBốn là có sẵn.\n--------------------------------------------------\n275511\nAgnosias are uncommon.\nMất nhận thức là tình trạng ít gặp.\n--------------------------------------------------\n275578\nWriting is impaired.\nSuy giảm khả năng viết.\n--------------------------------------------------\n277640\nHemoptysis occurs later.\nHo máu xảy ra sau đó.\n--------------------------------------------------\n278424\nCytopenias suggest hypersplenism.\nGiảm tế bào máu gợi ý cường lách.\n--------------------------------------------------\n278478\nReticulocytosis is usual.\nHồng cầu lưới bình thường.\n--------------------------------------------------\n278718\nSplenomegaly may develop.\nChứng lách to có thể phát triển.\n--------------------------------------------------\n278769\nThe RDW is high.\nRDW cao.\n--------------------------------------------------\n278771\nReticulocytopenia is present.\nGiảm bạch cầu lưới.\n--------------------------------------------------\n279176\n(See also Immunotherapeutics.)\n(Xem thêm Điều trị miễn dịch.)\n--------------------------------------------------\n279346\nHyperbilirubinemia may follow.\nCó thể tăng bilirubin.\n--------------------------------------------------\n279578\nHemolysis is extravascular.\nTan máu do ngoại mạch.\n--------------------------------------------------\n279817\nIron chelation is usually necessary.\nCần thải sắt.\n--------------------------------------------------\n280088\nAmyloidosis sometimes develops.\nĐôi khi tiến triển thành bệnh Ayloidosis.\n--------------------------------------------------\n280615\nTreat with chelation.\nĐiều trị bằng thải sắt.\n--------------------------------------------------\n280638\nHoneycombing is rare.\nTổ ong là rất hiếm.\n--------------------------------------------------\n280958\nTreatment reference 1.\nTài liệu tham khảo về điều trị 1.\n--------------------------------------------------\n281425\n(See also Alopecia.)\n(Xem thêm Rụng tóc.)\n--------------------------------------------------\n282284\nArthralgias are common.\nThường gặp đau khớp.\n--------------------------------------------------\n282801\nDevelopment is rapid.\nPhát triển nhanh.\n--------------------------------------------------\n283314\nCorticosteroids are contraindicated.\nCorticosteroid là chống chỉ định.\n--------------------------------------------------\n283343\nLeukocytosis is common.\nBệnh thường gây tăng bạch cầu.\n--------------------------------------------------\n283344\nBacteremia may occur.\nNhiễm khuẩn huyết có thể xảy ra.\n--------------------------------------------------\n283537\nDrain lesions.\nDẫn lưu tổn thương.\n--------------------------------------------------\n284149\nCause is unknown.\nChưa rõ nguyên nhân.\n--------------------------------------------------\n284429\nPapules are frequently painful.\nSẩn thường đau.\n--------------------------------------------------\n284474\nRecommend smoking cessation.\nĐề nghị ngừng hút thuốc.\n--------------------------------------------------\n285331\nPruritus is often present.\nNgứa thường xuyên.\n--------------------------------------------------\n285696\nRemove the draping.\nTháo toan phủ.\n--------------------------------------------------\n286265\nPain is usually absent.\nThường không đau.\n--------------------------------------------------\n286471\nKeep the mucosa taut.\nGiữ bột khô.\n--------------------------------------------------\n287254\nAnkylosis may follow.\nCó thể kéo theo dính khớp.\n--------------------------------------------------\n288272\n(See also Paracentesis.)\n(Xem thêm Chọc hút.)\n--------------------------------------------------\n290028\nMortality is rare.\nTỷ lệ tử vong là rất hiếm.\n--------------------------------------------------\n290049\nRespiration is shallow and rapid.\nThở nhanh nông.\n--------------------------------------------------\n290132\nPerforation causes peritonitis.\nThủng túi thừa gây viêm phúc mạc.\n--------------------------------------------------\n291989\nAntibiotics are ancillary.\nKháng sinh là bắt buộc.\n--------------------------------------------------\n292292\nCauses vary.\nCác nguyên nhân khác nhau.\n--------------------------------------------------\n292809\nDiarrhea usually occurs.\nThường xảy ra tiêu chảy.\n--------------------------------------------------\n292922\nDiarrhea is watery.\nTiêu chảy phân toàn nước.\n--------------------------------------------------\n292991\nSeverity is variable.\nMức độ nặng khác nhau.\n--------------------------------------------------\n293102\nPneumomediastinum is common.\nTràn khí trung thất là phổ biến.\n--------------------------------------------------\n293508\nWeight loss is common.\nThường sút cân.\n--------------------------------------------------\n293684\nTreatment is colectomy.\nĐiều trị là cắt đại tràng.\n--------------------------------------------------\n293772\nDyspnea is common.\nTriệu chứng khó thở hay gặp.\n--------------------------------------------------\n295503\nType 3 is rare).\nLoại 3 hiếm).\n--------------------------------------------------\n296648\nLeukopenia is absent.\nKhông có giảm bạch cầu.\n--------------------------------------------------\n299094\nExercise capacity improves.\nKhả năng gắng sức được cải thiện.\n--------------------------------------------------\n300299\nPrognosis is good.\nTiên lượng tốt.\n--------------------------------------------------\n301171\nPulses are normal.\nBắt mạch bình thường.\n--------------------------------------------------\n301266\n(See also Aneurysms\n(Xem thêm Phình mạch\n--------------------------------------------------\n301669\nThere is a leftward mean frontal axis shift.\nTrục lệch trái.\n--------------------------------------------------\n301734\nP waves vary.\nSóng P thay đổi.\n--------------------------------------------------\n302864\nRecommended therapy includes.\nLiệu pháp được khuyến nghị bao gồm.\n--------------------------------------------------\n304110\nCrystals are absent.\nKhông có tinh thể.\n--------------------------------------------------\n304688\nGeneral references 1.\nTuy nhiên, tỷ lệ chung đang giảm.\n--------------------------------------------------\n305642\nAnticipate pulmonary hypertension.\nDự đoán tăng áp lực động mạch phổi.\n--------------------------------------------------\n305899\nTable Table Table\nBảng Bảng Bảng\n--------------------------------------------------\n306287\nPro. Phd. Vu\nPGS. TS\n--------------------------------------------------\n306317\nSequence; (7).\nGiải trình tự gen; (7).\n--------------------------------------------------\n306321\nFindings: (1).\nKết quả nghiên cứu: (1).\n--------------------------------------------------\n306387\nNguyen Xuan Thuy.\nNguyễn Xuân Thuỳ.\n--------------------------------------------------\n306461\nInstructor: 1.\nThầy hướng dẫn: 1.\n--------------------------------------------------\n306616\nVu Long MD 2.\nVŨ LONG 2.\n--------------------------------------------------\n306630\nResults of treatment.\nKết quả điều trị của phác đồ TAC.\n--------------------------------------------------\n306776\nAsso. Prof 2.\nĐặng Thị Minh Nguyệt 2.\n--------------------------------------------------\n306872\n2) Assoc.\nNguyễn Văn Liệu; 2.\n--------------------------------------------------\n307414\nSupervisors: Bui Van Giang M D.\nBùi Văn Giang.\n--------------------------------------------------\n307415\nMai Van Vien M D.\nMai Văn Viện.\n--------------------------------------------------\n307825\nRate of recanalization.\nTỷ lệ tái thông mạch.\n--------------------------------------------------\n308011\nAcademic supervisor: Assoc.\nNgười hướng dẫn: Pgs.\n--------------------------------------------------\n308042\nNNT = 5.6.\nNNT = 5,6.\n--------------------------------------------------\n308150\nProposed supervisor: 1.\nNgười hướng dẫn: 1.\n--------------------------------------------------\n308492\nPham Quang Vinh.\nGS. TS Phạm Quang Vinh.\n--------------------------------------------------\n308593\nNguyen Viet Tien-Associate.\nNguyễn Viết Tiến PGS. TS.\n--------------------------------------------------\n308910\nST is 1.25%.\nTỷ lệ huyết khối trong stent là: 2,5%.\n--------------------------------------------------\n309412\nComplication: hematoma (1.30%).\nBiến chứng: Tụ máu (1,30%).\n--------------------------------------------------\n309692\nMale accounted for 97.27%.\nNam chiếm 97,27%.\n--------------------------------------------------\n310467\nDigestive diseases 12.3%.\nBệnh về tiêu hoá 12,3%.\n--------------------------------------------------\n310468\nHepatobiliary disease 5.26%.\nBệnh gan mật 5,26%.\n--------------------------------------------------\n310494\nCataracts 14%.\nĐục thuỷ tinh thể 14%.\n--------------------------------------------------\n310495\n10.5% diabetes\nBệnh tiểu đường 10,5\n--------------------------------------------------\n311070\n-Step 2.\n-Bước 2.\n--------------------------------------------------\n311766\nSurgical procedure 2.2.3.1.\nQuy trình phẫu thuật 2.2.3.1.\n--------------------------------------------------\n311785\n-Hepatitis markers.\n-Dấu ấn viêm gan.\n--------------------------------------------------\n311787\n-Preoperative liver biopsy.\n-Sinh thiết gan trước mổ.\n--------------------------------------------------\n311790\n-Alphafetoprotein before surgery.\n-Alphafetoprotein trước mổ.\n--------------------------------------------------\n311797\n-Postoperative pathological results.\n-Kết quả giải phẫu bệnh sau mổ.\n--------------------------------------------------\n311800\n-Postoperative time (days).\n-Thời gian trung tiện, hậu phẫu (ngày).\n--------------------------------------------------\n311834\nHEPATECTOMY SPECIFICATION 3.3.1.\nĐẶC ĐIỂM KĨ THUẬT CẮT GAN 2.3.1.\n--------------------------------------------------\n311846\nSURGERY RESULTS 3.4.1.\nKẾT QUẢ PHẪU THUẬT 2.4.1.\n--------------------------------------------------\n312078\nAllergic rhinitis 1.1.1.\nBệnh viêm mũi dị ứng 1.1.1.\n--------------------------------------------------\n312334\nDuration: 6 months.\nThời gian sử dụng là 6 tháng.\n--------------------------------------------------\n312340\nTable 3.\nBảng 3.\n--------------------------------------------------\n312811\n-Unipolar electric knife.\n-Dao điện đơn cực.\n--------------------------------------------------\n313010\nTable 0.8-3.9.\nBảng 3.8-3.9.\n--------------------------------------------------\n313020\nTable 0.14-3.15.\nBảng 3.14-3.15.\n--------------------------------------------------\n313023\nTable 0.20-3.22.\nBảng 3.20-3.22.\n--------------------------------------------------\n313155\nTable 4.40.\nBảng 3.40.\n--------------------------------------------------\n313258\nTable 3.5.\nBảng 3.5.\n--------------------------------------------------\n313284\nResearch variable/indicator 2.2.3.1.\nChỉ số nghiên cứu 2.2.3.1.\n--------------------------------------------------\n313289\nResearch implementation 2.3.1.\nTổ chức nghiên cứu 2.3.1.\n--------------------------------------------------\n313292\nObservation practice 2.3.2.2.\nQuan sát thực hành 2.3.2.2.\n--------------------------------------------------\n313560\nBox 3.8.\nHộp 3.8.\n--------------------------------------------------\n313563\nTable 3.43.\nBảng 3.43.\n--------------------------------------------------\n313646\nChapter 2.\nChơng 2.\n--------------------------------------------------\n313677\nImplement interventions 2.4.1.\nTriển khai can thiệp 2.4.1.\n--------------------------------------------------\n313878\n(Table 3.14-3.15) 4.3\n(Bảng 3.14-3.15\n--------------------------------------------------\n314359\nProposal 1.\nKiến nghị 1.\n--------------------------------------------------\n314399\nChart 3.4.\nHình 3.4.\n--------------------------------------------------\n314405\n(7.3-594.1) ref.\n(7,3-594,1) ref.\n--------------------------------------------------\n314407\n(0.7-23.4) ref.\n(0,7-23,4) ref.\n--------------------------------------------------\n314409\n(0.9-1459.5) ref.\n(0,9-1459,5) ref.\n--------------------------------------------------\n314411\n[0.6-9.9] ref.\n[0,6-9,9] ref.\n--------------------------------------------------\n314413\n[0.1-31.2] ref.\n[0,1-31,2] ref.\n--------------------------------------------------\n314659\nData collection 2.3.2.1.\nKỹ thuật thu thập thông tin 2.3.2.1.\n--------------------------------------------------\n314829\nChapter 3.\nChương 3.\n--------------------------------------------------\n314840\nFigure 3.15-3.16.\nBảng 3.15-3.16.\n--------------------------------------------------\n314845\nFigure 3.29.\nBảng 3.29.\n--------------------------------------------------\n314864\nTable 3.45.\nBảng 3.45.\n--------------------------------------------------\n314918\nAsthma 1.1.1.\nBệnh hen phế quản 1.1.1.\n--------------------------------------------------\n315246\nLITERATURE OVERVIEW 1.1.\nTỔNG QUAN 1.1.\n--------------------------------------------------\n315539\n-Shaggy luminal contour.\n-Đường bờ trong lòng ruột không đều.\n--------------------------------------------------\n315745\nMoney well spent?\nTiền có được chi tiêu đúng?\n--------------------------------------------------\n315811\nQuinoa Pronounced Keen-wha.\nDiệm mạch Phát âm là Keen-wha.\n--------------------------------------------------\n315929\nThat's epigenetics.\nĐó là biểu sinh học.\n--------------------------------------------------\n316408\nSplenectomy was performed.\nCắt lách đã được thực hiện.\n--------------------------------------------------\n316735\n2 points in TI-RADS.\n2 điểm TI-RADS.\n--------------------------------------------------\n316825\n10A and 10B\nHình 10B\n--------------------------------------------------\n316905\nFIGURE 2-25.\nHÌNH 2-25.\n--------------------------------------------------\n316910\nE-FIGURE 2-6.\ne-HÌNH 2-6.\n--------------------------------------------------\n316914\nE-FIGURE 2-7.\ne-HÌNH 2-7.\n--------------------------------------------------\n316915\nEmphysematous cholecystitis.\nViêm túi mật khí thũng.\n--------------------------------------------------\n316922\nE-FIGURE 2-9.\ne-HÌNH 2-9.\n--------------------------------------------------\n316942\nFIGURE 2-21.\nHÌNH 2-21.\n--------------------------------------------------\n316943\nGallbladder edema.\nTúi mật phù nề.\n--------------------------------------------------\n316951\nFIGURE 2-22.\nHÌNH 2-22.\n--------------------------------------------------\n316959\nFIGURE 2-23.\nHÌNH 2-23.\n--------------------------------------------------\n316971\nE-FIGURE 2-5.\ne-HÌNH 2-5.\n--------------------------------------------------\n317008\nF = femur.\nF = femur: xương đùi.\n--------------------------------------------------\n317200\nBut why?\nTại sao vậy?\n--------------------------------------------------\n317353\nApparently it does.\nDĩ nhiên là có.\n--------------------------------------------------\n317709\nWhat Causes Acne?\nCác nguyên nhân của trứng cá là gì?\n--------------------------------------------------\n317724\nWho Gets Acne?\nNhững ai có thể bị trứng cá?\n--------------------------------------------------\n317973\nSimply put, research!\nNói một cách đơn giản, là nghiên cứu!\n--------------------------------------------------\n318176\nThe results?\nKết quả là gì?\n--------------------------------------------------\n318198\nLinked to Cancer?\nCó nguy cơ ung thư?\n--------------------------------------------------\n318340\nTired blood (anemia).\nHao máu (Thiếu máu).\n--------------------------------------------------\n318341\nBirth control.\nNgừa thai.\n--------------------------------------------------\n318343\nHeadache.\nNhức đầu.\n--------------------------------------------------\n318344\nHeart problems.\nVấn đề tim mạch.\n--------------------------------------------------\n318347\nOther conditions.\nCác bệnh khác.\n--------------------------------------------------\n318348\nSnakebites.\nRắn cắn.\n--------------------------------------------------\n318349\nGum disease (gingivitis).\nBệnh nướu răng (viêm lợi).\n--------------------------------------------------\n318369\nWhat Are Parabens?\nParaben là gì?\n--------------------------------------------------\n318452\nYes, its true.\nQuả đúng thế.\n--------------------------------------------------\n318962\nIt's just faeces.\nMishori nói Đó chỉ là phân.\n--------------------------------------------------\n319111\nAvoid fried foods.\nTránh chiên thức ăn.\n--------------------------------------------------\n319190\nSurvival or risk?\nVượt qua hay nguy cơ?\n--------------------------------------------------\n319191\nWho Catches Cold?\nAi bị cảm lạnh?\n--------------------------------------------------\n319466\n(WHO, 1986).\n(TCYTTG, 1986).\n--------------------------------------------------\n319584\nMindset is all.\nTư duy là tất cả.\n--------------------------------------------------\n319886\nHand-foot-mouth disease\nBệnh tay-chân-miệng\n--------------------------------------------------\n319887\nCoxsackievirus infection\nNhiễm Coxsackievirus\n--------------------------------------------------\n319892\nFever\nSốt\n--------------------------------------------------\n319893\nHeadache\nNhức đầu\n--------------------------------------------------\n319894\nLoss of appetite\nMất cảm giác ngon miệng\n--------------------------------------------------\n319896\nSore throat\nĐau họng\n--------------------------------------------------\n319898\nSigns and tests\nCác dấu hiệu và xét nghiệm kiểm tra\n--------------------------------------------------\n319900\nTreatment\nĐiều trị\n--------------------------------------------------\n319902\nExpectations (prognosis)\nKỳ vọng (tiên lượng)\n--------------------------------------------------\n319904\nDehydration\nMất nước\n--------------------------------------------------\n319905\nFebrile seizures\nCo giật do sốt cao\n--------------------------------------------------\n319912\n-Weight loss\n-Giảm cân\n--------------------------------------------------\n319913\n-Irritability\n-Khó chịu\n--------------------------------------------------\n319914\n-Lethargy\n-Thờ ơ\n--------------------------------------------------\n319916\nPrevention\nPhòng ngừa\n--------------------------------------------------\n319948\nUreteral stones\nSỏi niệu quản\n--------------------------------------------------\n319967\nUrethral diverticulum\nTúi thừa niệu đạo\n--------------------------------------------------\n319992\nAdenomatous polyp\nPolyp tuyến\n--------------------------------------------------\n319998\nRectal cancer\nUng thư trực tràng\n--------------------------------------------------\n320014\nCrohn's disease\nBệnh Crohn\n--------------------------------------------------\n320080\nCRP was 2.\nCRP là 2.\n--------------------------------------------------\n320098\nCystoscopy was negative.\nNội soi bàng quang bình thường.\n--------------------------------------------------\n320185\nDon't worry.\nĐừng lo lắng.\n--------------------------------------------------\n320823\nRenal osteodystrophy\nLoạn dưỡng xương do thận\n--------------------------------------------------\n320832\nMalignant hyperthermia\nTăng thân nhiệt ác tính\n--------------------------------------------------\n320868\nMalignant hyperthermia-case report\nTăng thân nhiệt ác tính-ca lâm sàng\n--------------------------------------------------\n321171\nSynthesis oxadiazolo[3,4-c]quinolon-4-3-oxid\nTổng hợp oxadiazolo[3,4-c]quinolon-4-3-oxid\n--------------------------------------------------\n321475\nShaken baby syndrome\nHội chứng trẻ bị lắc\n--------------------------------------------------\n321519\nPulmonary hamartoma\nHamartôm ở phổi\n--------------------------------------------------\n321581\nDegenerative joint disease\nBệnh thoái hoá khớp\n--------------------------------------------------\n321652\nPancreatoduodenal injury\nChấn thương tá tuỵ\n--------------------------------------------------\n322485\nMediastinal abcess\nÁp-xe trung thất\n--------------------------------------------------\n322491\nThoracic-abdominal wound\nVết thương ngực bụng\n--------------------------------------------------\n322668\nBreast self-examination\nTự khám vú\n--------------------------------------------------\n323033\nBiliary acute pancreatitis\nViêm tuỵ cấp trên bệnh nhân sỏi mật\n--------------------------------------------------\n323138\nCraniopharyngiomas endoscopic surgery\nPhẫu thuật nội soi u sọ hầu\n--------------------------------------------------\n323212\nHistory of esophagectomy\nTổng quan về cắt thực quản\n--------------------------------------------------\n323364\nStreptococcus suis meningitis\nViêm màng não mủ do streptococcus suis\n--------------------------------------------------\n323455\nPerioperative respiratory failure\nSuy hô hấp chu phẫu\n--------------------------------------------------\n323893\nSuicide caused burn\nBỏng do tự thiêu\n--------------------------------------------------\n324674\nPancreatic cysts neoplasm\nU nang tuỵ\n--------------------------------------------------\n325322\nVenous flow-through flaps\nVạt tĩnh mạch\n--------------------------------------------------\n325374\nNocardia necrotic scleritis\nViêm củng mạc hoại tử do Nocardia\n--------------------------------------------------\n326019\nPancreatoduodenectomy for trauma\nCắt khối tá tuỵ do chấn thương\n--------------------------------------------------\n326368\nCutaneous tuberculosis\nBệnh lao da\n--------------------------------------------------\n326386\nHigh-frequency digestive cancer\nUng thư tiêu hoá thường gặp\n--------------------------------------------------\n327051\nEndogenous fungal endophthalmitis\nViêm nội nhãn nội sinh do nấm\n--------------------------------------------------\n327375\nMaastricht IV consensus\nĐồng thuận Maastricht IV\n--------------------------------------------------\n327534\nOvarian reserve testing\nCác test dự trữ buồng trứng\n--------------------------------------------------\n329260\nNecrotizing externam otitis\nViêm tai ngoài hoại tử\n--------------------------------------------------\n329495\nSphincter factor 1.1.2.5.\nYếu tố c th t 1.1.2.5.\n--------------------------------------------------\n329685\nSynthesis of isoxazolo[4,3-c]quinolon-4-on\nTổng hợp isoxazolo[4,3-c]quinolon-4-on\n--------------------------------------------------\n329831\nFailure: 13 cases.\nThất bại: 13 trường hợp.\n--------------------------------------------------\n329872\nNutrition and cancer.\nDinh dưỡng và Ung thư.\n--------------------------------------------------\n330044\nMechanical factors 1.1.2.2.\nYếu tố c học 1.1.2.2.\n--------------------------------------------------\n330154\nRelapses are common.\nTái phát bệnh phổ biến.\n--------------------------------------------------\n330155\nComplication rate: 1.9%.\nTai biến gặp: 1,9%.\n--------------------------------------------------\n330180\nSample size: 250.\nCỡ mẫu: 250 mẫu.\n--------------------------------------------------\n330305\nTECHNICAL CHARACTERISTICS 4.3.1.\nKỸ THUẬT 4.3.1.\n--------------------------------------------------\n330660\nPelvic exenteration\nPhẫu thuật đoạn chậu\n--------------------------------------------------\n330728\nKeywords: Fontan completion.\nTừ khoá: Phẫu thuật Fontan.\n--------------------------------------------------\n331348\naureus (8.5%).\naureus (8,5%).\n--------------------------------------------------\n331414\nSubclinical 1.2.3.1.\nCận lâm sàng 1.2.3.1.\n--------------------------------------------------\n331657\nIncretin and diabetes.\nIncretin và bệnh đái tháo đường.\n--------------------------------------------------\n332225\nMethod: Restrospective study.\nPhương pháp nghiên cứu: nghiên cứu hồi cứu.\n--------------------------------------------------\n332277\nSplenectomy is valueless.\nCắt lách là không có giá trị.\n--------------------------------------------------\n332279\nChanges are symmetric.\nBiến đổi đối xứng.\n--------------------------------------------------\n332561\nComplication rate: 7.5%.\nTai biến gặp: 7,5%.\n--------------------------------------------------\n332848\n-Pathologic results 2.2.5.7.\n-Giải phẫu bệnh 2.2.5.7.\n--------------------------------------------------\n333353\nCholecystectomy in 87.7%.\nCắt túi mật: 87,7%.\n--------------------------------------------------\n333433\nResults: Female 83.3%.\nKết quả: Nữ chiếm đa số 83,3%.\n--------------------------------------------------\n333451\nKeywords: penile cancer\nTừ khoá: ung thư dương vật\n--------------------------------------------------\n333471\nLate outcomes 4.4.3.1.\nKết quả xa 4.4.3.1.\n--------------------------------------------------\n334017\nKeywords: dyslipidemia, HIV/AIDS.\nTừ khoá: rối loạn lipid máu, HIV/AIDS, ARV.\n--------------------------------------------------\n334423\nKeys word: Candidemia\nTừ khoá: Candida huyết\n--------------------------------------------------\n334930\nLymphadenopathy is rare.\nHiếm có hạch to.\n--------------------------------------------------\n335036\nKeywords: Aneurysms, microsurgical\nTừ khoá: phình mạch, vi phẫu\n--------------------------------------------------\n335289\nCase-series study design.\nThiết kế nghiên cứu hàng loạt ca.\n--------------------------------------------------\n335366\nVu Hong Cuong.\nVũ Hồng Cương.\n--------------------------------------------------\n335415\nNo complicationoccurs.\nÍt tai biến biến chứng.\n--------------------------------------------------\n335430\nComplication: 7% (3cases).\nDi chứng: 7% (3 ca).\n--------------------------------------------------\n336107\nAll patientshave fever.\nTất cả trẻ đều có sốt.\n--------------------------------------------------\n336133\nShort-term outcomes 4.2.2.1.\nKết quả sớm 4.2.2.1.\n--------------------------------------------------\n336463\nDemarcation line marked.\nĐánh dấu diện cắt gan.\n--------------------------------------------------\n336578\n53 or No.\n53 hoặc No.\n--------------------------------------------------\n336635\nKeywords: Meckel's diverticulum\nTừ khoá: túi thừa Meckel\n--------------------------------------------------\n336750\nMRI procedure 2.2.3.2.\nQuy trình chụp C T 2.2.3.2.\n--------------------------------------------------\n337044\nKeywords: antibiotics, surgery.\nTừ khoá: Kháng sinh, phẫu thuật.\n--------------------------------------------------\n337179\nTonsilitis: clinico-pathological confontation\nViêm amiđan: đối chiếu lâm sàng-giải phẫu bệnh\n--------------------------------------------------\n337286\nSome examples follow.\nMột số ví dụ sau.\n","output_type":"stream"}],"execution_count":223},{"cell_type":"code","source":"id_str=\"\"\"\n6774\n9109\n20363\n21270\n38918\n55340\n66375\n66869\n67282\n69814\n73816\n77870\n85549\n91182\n92791\n95305\n95357\n95831\n98855\n99987\n104794\n108129\n118069\n124677\n131061\n131062\n134440\n141880\n144731\n146326\n149586\n151032\n163094\n169020\n169841\n170427\n172997\n176623\n178611\n178792\n187311\n208567\n213528\n268450\n305899\n306287\n306776\n306872\n313010\n313020\n313023\n313878\n330044\n\"\"\"\nids = id_str.split()\nremove_ids = set()\nfor i in ids:\n    try:\n        id_int = int(i)\n        remove_ids.add(i)\n    except:\n        continue\nlen(remove_ids)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:36:09.772774Z","iopub.execute_input":"2025-12-21T13:36:09.773181Z","iopub.status.idle":"2025-12-21T13:36:09.781915Z","shell.execute_reply.started":"2025-12-21T13:36:09.773152Z","shell.execute_reply":"2025-12-21T13:36:09.780767Z"}},"outputs":[{"execution_count":225,"output_type":"execute_result","data":{"text/plain":"53"},"metadata":{}}],"execution_count":225},{"cell_type":"code","source":"ens = [s for i, s in enumerate(ens) if i not in remove_ids]\nvis = [s for i, s in enumerate(vis) if i not in remove_ids]","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:36:29.777526Z","iopub.execute_input":"2025-12-21T13:36:29.777879Z","iopub.status.idle":"2025-12-21T13:36:29.949852Z","shell.execute_reply.started":"2025-12-21T13:36:29.777851Z","shell.execute_reply":"2025-12-21T13:36:29.947995Z"}},"outputs":[],"execution_count":226},{"cell_type":"markdown","source":"# Save","metadata":{}},{"cell_type":"code","source":"print(len(ens))\nprint(len(vis))","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:37:07.370268Z","iopub.execute_input":"2025-12-21T13:37:07.371532Z","iopub.status.idle":"2025-12-21T13:37:07.377087Z","shell.execute_reply.started":"2025-12-21T13:37:07.371300Z","shell.execute_reply":"2025-12-21T13:37:07.375856Z"}},"outputs":[{"name":"stdout","text":"337597\n337597\n","output_type":"stream"}],"execution_count":227},{"cell_type":"code","source":"with open('clean_train.en.txt', 'w', encoding='utf-8') as f:\n    f.write('\\n'.join(ens))\nwith open('clean_train.vi.txt', 'w', encoding='utf-8') as f:\n    f.write('\\n'.join(vis))","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-12-21T13:38:33.196224Z","iopub.execute_input":"2025-12-21T13:38:33.196559Z","iopub.status.idle":"2025-12-21T13:38:33.831852Z","shell.execute_reply.started":"2025-12-21T13:38:33.196532Z","shell.execute_reply":"2025-12-21T13:38:33.830594Z"}},"outputs":[],"execution_count":228}]}